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ABSTRACT 
 
Antimicrobial resistance is a threat to human and animal health. There is 
widespread, unregulated use of antimicrobials in Tanzania in poultry production, 
which may impose selective pressure on gastrointestinal commensals. The 
indiscriminate use of antimicrobials in health care and agriculture has exerted 
selective pressure among commensal bacteria such as Escherichia coli enabling 
them to acquire fitness against antimicrobials. Extensive research has been 
conducted in human and animal pathogens, but few studies have investigated 
antimicrobial resistance in enteric commensals. When enteric commensals share 
the same niche with pathogens, there is potential for lateral gene transfer 
between commensals and pathogens. One of the aims of the present study was 
to determine the prevalence of antimicrobial resistant commensal coliforms 
across four poultry farm types in Arusha and Moshi, Northern Zone, Tanzania. 
The second was to determine prevalence of AMR in commensal E. coli isolates 
using different thresholds for interpret resistance, and to examine the impact of 
methodology and thresholds on apparent AMR prevalence.  
 
Samples were collected from Moshi and Arusha urban districts. Ten wards 
were randomly chosen in each district, with random selection of one 
representative farm in each ward per production system (extensive, semi-
intensive, indigenous intensive and broiler intensive). In each farm, cloacal 
swabs were collected from 10 chickens. Resistance against four antimicrobial 
compounds was explored, selected based on common use (tetracycline) or 
importance to human health based on the World Health Organization’s list of 
Critically Important Antimicrobials (ciprofloxacin, ceftazidime and imipenem). 
The breakpoint plate method was used in screening for presence of resistant 
coliforms in cloacal samples in Tanzania whilst confirmatory testing was 
conducted in Glasgow on a subset of plate weeps. Chromogenic agar was used in 
identification of individual E. coli isolates whilst uidA PCR was used for 
confirmation of the species. To analyse the susceptibility of individual isolates, 
disc diffusion testing was used. Inhibition zone diameters were interpreted using 
clinical breakpoints (CB), ecological cutoffs (ECOFFS) (provided by the European 
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Committee on Antimicrobial Susceptibility Testing (EUCAST) and normalised 
resistance interpretation based wild type cut-offs (COWT).  
No correlation was found between prevalence data generated in Tanzania 
and Glasgow. Resistance to each of the four compounds was seen at least once 
in every farm. There was no consistent pattern revealing a clear association 
between intensification of poultry production and prevalence of resistance. 
Tetraycline resistance was consistently higher across farm types compared to 
other antimicrobials based on both disc diffusion method and the breakpoint 
plate method. According to the CB and COWT interpretation, the prevalence of 
AMR was low for ceftazidime and imipenem (< 4%), intermediate for 
ciprofloxacin, and high for tetracycline (> 67%). Relatively high prevalence was 
observed based on ECOFFS, e.g. 45.8% for ceftazidime and 64.4% for imipenem. 
These results suggest that interpretation of resistance can be impacted by the 
type of threshold used. Our study reveals that healthy poultry are reservoirs of 
resistant E. coli. Thus, there may be a risk of transmission of resistant bacteria 
in and out of the farms, for example, through contaminated water, use of 
poultry manure in crop production, or through the food chain. Control strategies 
need to be developed, including further studies to determine factors that may 
be contributing to the AMR problem in poultry farms.  
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CHAPTER ONE 
 
PREVALENCE OF ANTIMICROBIAL RESISTANCE 
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1.1 Introduction 
1.1.1 Prevalence of antimicrobial resistance 
Antimicrobial resistance (AMR) is regarded as one of the major public 
health problems of the 21st century. According to a high profile report, AMR 
causes more than 700,000 deaths each year around the world (O’Neill, 2014). 
Genuine data of the worldwide burden of AMR is still missing, as the current 
information is not truly illustrative of the worldwide situation, especially in 
developing nations. At best, existing studies provide estimates largely based on 
collation of small scale or individual studies that vary greatly in setting, scope, 
sampling frame and methodology often compelling bold inferences to be made 
from very limited data. Due to such huge information gaps in the existing data 
on AMR, the status globally is regarded partial and quite tentative. Moreover, 
although there are a few existing reports in low-income countries (e.g. situation 
analysis in Mozambique (Sigauque and Saide, 2016) or the Tanzania AMR National 
Action Plan (Hakanen et al., 2017)), the available information, for the most 
part, addresses the situation in developed countries (European Centre for 
Disease Prevention and Control (ECDC), 2009) and US (Centers for Disease 
Control and Prevention (CDC), 2013) while underestimating the real condition in 
the developing countries. Despite being published five years apart, the European 
Centre for Disease Prevention and Control report (ECDC, 2009) and AMR review 
report (O’Neill, 2014), did not account for population-based surveillance data. 
Their inferences were largely dependent on data provided by the European 
Antimicrobial Resistance Surveillance network (EARS-Net) that only records 
invasive infections diagnosed in hospitals and for a variable proportion of the 
total number of hospitals in each country. This implies that significant 
information from some hospitals was left out. On the other hand, population-
based surveillance which is clearly unrepresented in these reports has the 
advantage of providing additional information about asymptomatic carriage of 
resistant bacteria which could spill over to clinics during visits at any given 
opportunity. Asymptomatic carriage in the healthy population can provide an 
indication of the existence of other exogenous sources of AMR bacteria and 
determinants other than hospitals and this includes other stressors prompting 
the development of antimicrobial-resistant microorganisms in the community, 
which could have the potential of causing high levels of resistance in the healthy 
population. These may not be noticed unless the healthy population is screened. 
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As of late, there is clear evidence of acquisition of AMR through food, between 
animals and humans although the directionality has not been clearly established 
(Muloi et al., 2018). Ideally, the AMR prevalence seen in hospitals could be a 
function of the general population, which only involves reported cases of ill 
individuals whilst the healthy population carrying AMR remains unchecked. A 
systematic review that was conducted to determine the role of farm animals on 
the emergence and dissemination of AMR bacteria and their determinants to 
humans discovered that only 8 studies (18%) suggest a possible transmission of 
AMR from food animals to humans, 25 studies (56%) suggest transmission 
between animals and humans without a clear direction specified and 12 studies 
(26%) did not support transmission at all (Muloi et al., 2018).  
 
Even with these limitations, the global situation of AMR is alarming. According to 
the US CDC, more than two million people every year are affected with 
antimicrobial-resistant infections, with at least 23 000 dying as a result of the 
infection  in US (CDC, 2013). On the other hand, each year in Europe, it has been 
estimated that 400 000 infections and 25 000 deaths occur due to the most 
frequent multidrug-resistant (i.e. resistant to three or more different 
antimicrobial classes) bacteria (Staphylococcus aureus, Escherichia coli, 
Enterococcus faecium, Streptococcus pneumoniae, Klebsiella pneumoniae and 
Pseudomonas aeruginosa) (ECDC, 2009). Common infections in neonatal intensive 
care are becoming extremely difficult and sometimes impossible to treat (Stoll 
et al., 2010). Hospital based studies in developing countries have shown that out 
of 834 pathogens causing neonatal sepsis in the first 3 days of life, resistant 
Klebsiella is the leading pathogen causing up to 26% of all infections followed by 
resistant E. coli and other gram positive bacteria such as S. aureus causing 13% 
to 17% of the infections (Nathoo et al., 1990; Sugandhi et al., 1993; Zaidi et al., 
2009). Similarly, for community acquired neonatal infection resistant gram-
negative bacteria are still the most commonly isolated pathogens beginning 
notably resistant Klebsiella spp. and resistant E. coli (Zaidi et al., 2009). 
 
Antimicrobial resistance as mentioned below in developing countries is 
yet to be fully addressed, as there is quite significant lack of sufficient data on 
the pattern of resistance in most countries. Due to absence of effective 
surveillance systems, efficient point of care diagnostic tools to detect AMR, 
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standardised guidelines for selection of appropriate antimicrobial therapy and 
poor dissemination of research information on the AMR pattern, most of the 
health systems are left stranded with the lack of up to date information on the 
AMR pattern within their populations, subsequently leading to the difficulty of 
making a decision on the choice of antimicrobial for specific infection 
(Ayukekbong et al., 2017). Thus, health professionals in these countries use 
multiple or more broad-spectrum antimicrobials to treat infections caused by 
several bacteria or those for which establishing the aetiology agent of the 
disease is deemed difficult or takes a quite a while (Neu, 1992). This practice 
increases resistance as the drug applies selective pressure not only upon the 
causative agent, but also upon a vast fraction of the patient's microbiota 
including the commensals (Calva et al., 1996). Moreover, the lack of proper 
enforcement and implementation of regulatory systems and absence of 
stewardship programs in some countries provide favourable conditions for 
continuation of imprudent use of antimicrobials (e.g. National Action Plan in 
Tanzania). In developing countries, more than 1000 cases for every 100 000 
individuals yearly were infected with multidrug resistant typhoid serotypes 
(Crump et al., 2003). It is thought that the development and dissemination of 
typhoid serotypes that are resistant to various antimicrobials such as ampicillin, 
chloramphenicol and co-trimoxazole (trimethoprim sulfamethoxazole), in part 
could be the reasons for persistence of the disease. On the other hand, in 
Pakistan and India, where carbapenems  are used widely, outbreaks of 
carbapenem resistant Escherichia coli and Klebsiella pneumonia have frequently 
been reported (Poirel et al., 2011). To make matters worse, some of these 
resistant clones and their plasmids have spread to other countries including 
developed countries. A good example is the emergence of New Delhi metallo-β-
lactamase (NDM-1) plasmid mediated carbapenem resistance that spread from 
India to Europe, USA and Africa (Kumarasamy et al., 2010; Poirel et al., 2011). 
Another good example is multidrug resistant Salmonella Typhi, which emerged in 
1987 and spread throughout the Indian subcontinent and South East Asia (Mirza 
et al., 1996). In that study, it was reported that 69% of Salmonella Typhi that 
were isolated from blood were multidrug resistant. Due to this observation, 
fluoroquinolones have become first line drugs for such Salmonella infections. 
However, epidemics of infections associated with ciprofloxacin resistant S. Typhi 
have been reported in Tajikistan (Ridley and Threlfall, 1998). These isolates 
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have been reported to carry large, self-transmissible plasmids, which encode 
resistance to each of the first line drugs and can be transferred to other 
pathogens. 
 
Antimicrobial resistance in most African countries is quite widespread, 
particularly in aetiological agents of disease. For instance, in Kilifi, Kenya, over 
half of the non-typhoidal Salmonella isolates from children were multidrug 
resistant (Oundo et al., 2000). A review study conducted to capture the situation 
in the whole of Africa, despite of lack of data from more than 40% of countries 
in the African continent, revealed that the median resistance of Escherichia coli 
to trimethoprim and gentamycin was 88.1%, 80.7% respectively whilst resistance 
to other antimicrobials such as carbapenem was common in P. aeruginosa 
(Tadesse et al., 2017). Between the latter study and Ampaire et al. (2016), who 
conducted a review study in East Africa, there is a close agreement which 
reveals high levels of resistance to common antimicrobials with estimates 
ranging approximately between 50% and 100%, particularly for ampicillin and 
cotrimoxazole (Otage, 2015). Gram-negative bacteria, particularly Klebsiella 
spp. and E. coli appear to be commonly resistant to gentamycin with estimates 
ranging between 20% to 47% (Mugalu et al., 2006) whilst gram-positive bacteria 
have been reported to be commonly resistant to ampicillin (100%) (Mulatu et al., 
2014), gentamicin and ceftriaxone (50% to 100%) (Muluye et al., 2014) with 
methicillin-resistant Staphylococcus aureus prevalences ranging from 2.6% to 
4.0% (Demilie et al., 2018). Short clinical studies in Tanzania involving children 
and pregnant women have revealed higher resistance rates in Klebsiella spp. 
than E. coli (Festo et al., 2011). There is likewise clear evidence showing 
growing AMR of nosocomial pathogens. For instance, resistance against 
gentamicin in E. coli has been reported to range from 7% at Muhimbili National 
hospitals (MNH) in 2003 to more than 44% in the same hospital in 2011 (Lyamuya 
et al., 2011; Rimoy et al., 2008). Molecular characterization has enabled the 
detection of antimicrobial resistant clones in some countries where there was no 
past evidence of their existence. For instance, in Tanzania Mshana and 
colleagues (2011) reported the presence of Extended Beta-Lactamase producing 
(CTX - M positive) E. coli, sequence (ST) 131, which has also been found in 
Canada, India, Kuwait, France and Switzerland (Nicolas-Chanoine et al., 2007;  
Coque et al., 2008). 
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1.1.2 Use of antimicrobials in animal production 
Antimicrobials have been used in animals for a long time for treatment of 
diseases, prevention and control of diseases and as growth promoters. 
Metaphylatically, because of infectious disease, the whole flock is usually 
treated to prevent the dissemination of illness in the flock, despite the 
exhibition of clinical symptoms in a few animals. The process involves the 
provision of high doses of antimicrobials for a short time frame whilst in 
prophylaxis, antimicrobials are administered in feed or drinking water in low 
doses for a longer period of time, usually for several weeks. During this time, 
animals are not manifesting any clinical signs, but the risk of infection exists 
(Ndashe et al., 2016). The use of antimicrobials as growth promoters stems back 
to the 1950s (Jukes et al., 1950), when Stokstad and Jukes found out that small 
subtherapeutic doses of penicillin and tetracycline could enhance weight gain. 
However, as of present a number of countries have made an effort to ban the 
use of antimicrobials for subtherapeutic purposes. For instance, in the European 
Union use of antimicrobials for growth promotion was banned in 2006 (Cogliani 
et al., 2011). 
 
Due to the frequent use of antimicrobials, it is thought that food animals 
could be substantial reservoirs of antimicrobial-resistant bacteria as the food 
production chain is an ecosystem composed of different ecological niches, which 
involve numerous bacteria co-existing and conceivably being exposed to 
selection pressure (Acar and Moulin, 2006). They can be transmitted directly or 
indirectly to humans through food consumption or direct and indirect contact 
with colonised or infected animals or through contact with excreta, such as 
urine or faeces, or blood (Chuang et al., 2015). Occupationally exposed workers 
such as veterinarians, farmers, abattoir workers and food handlers, as well as 
those directly in contact with animals, are at high risk of being colonized or 
infected with antimicrobial-resistant bacteria (Marshall and Levy, 2011; Aubry-
Damon et al., 2004).  A study of French pig farmers and non-farmers showed 
that the pattern of co-resistance to ampicillin-streptomycin-cotrimoxazole was 
significantly more common among E. coli isolated from pig farmers compared 
with E. coli isolated from non-farmers (Aubry-Damon et al., 2004). Exposed 
workers and their families provide a likely route for entry of antimicrobial-
resistant bacteria and AMR genes into the community and healthcare settings 
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where subsequent exchanges and the acquisition of resistance mechanisms are 
evident (Marshall and Levy, 2011). Moreover, a large proportion of antimicrobials 
are not transformed into inactive forms once administered in animals and 
subsequently get retained in the tissue of the animals or disseminated in the 
environment which is another important reservoir of antimicrobial resistant 
bacteria or antimicrobial residues (Zhu et al.,2013). Antimicrobial residues, such 
as fluoroquinolones, macrolides, aminoglycosides, and tetracyclines (Kümmerer, 
2009) have been identified broadly in the environment. Studies demonstrate 
major sources of contamination for antimicrobial-resistant bacteria and 
resistance genes in the environment include wastewater from farms or hospitals 
and feacal waste (in some areas via open defecation), animal husbandry and 
wildlife (Ortiz et al., 2016; Bondarczuk et al., 2016; Husman and Larsson, 2016). 
High prevalence of residues in various ecological niches in the farm-to-fork 
continuum is thought to enhance the pool of antimicrobial resistant bacteria and 
AMR genes in the ecosystem because of exposure to sub-inhibitory 
concentrations of the residues (Acquaah-Mensah et al., 2012). There is also 
evidence indicating the possibility of transmission of  antimicrobial resistant 
airborne pathogens (Huijbers et al., 2015), e.g. resistant Coxiella spp. in the air 
and dust particles, which can lead to Q-fever (Dorko et al., 2012).  
 
In many countries, clear linkage of AMR in animals and humans has not 
been ascertained. A great part of evidence identifying the potential transfer of 
resistance problem from animals and humans originates from a consideration of 
the epidemiology of zoonoses, mainly Salmonella and Campylobacter or 
indicator organisms such as E. coli and enterococci, which can be carried 
asymptomatically by healthy humans and animals. However, the epidemiology of 
these diseases is far from simple since there are many possible sources other 
than food animal of animal origin (Phillips et al., 2003). When antimicrobials are 
used in animals, resistance is likely to be selected in commensal and pathogenic 
intestinal flora and other colonized or infected body sites leading to an increase 
in prevalence (Aarestrup et al., 2000; Bager et al., 2002). Humans and other 
animals can acquire resistant pathogens and commensal organisms by ingesting 
them. Contaminated meat and other cross-contaminated foods cause millions of 
cases of gastrointestinal illnesses such as salmonellosis and campylobacteriosis 
each year in the USA alone (Scallan et al., 2011). The threat that antimicrobial 
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use in food-producing animals poses to human health via this route has been 
estimated using microbial risk assessment models  (Mcewen, 2012). Using an 
exposure-based model, one study assessed how many cases of Campylobacter 
jejuni infection (i.e. resistant cases) could arise from contaminated ground 
beef. The study estimated 12 cases in the USA after one year of fluoroquinolone 
use in cattle, rising to 44 cases and one death after 10 years (Anderson et al., 
2001). Another good example is the vancomycin-resistant enterococci (VRE), 
which normally colonize the gut, and have been noted to acquire resistance to 
multiple antimicrobials over time, making the glycopeptide vancomycin one of 
the last therapeutic options. The epidemiology of VRE differs substantially 
between the USA and Europe. In Europe, Enterococcus faecium carrying the vanA 
element for vancomycin resistance was commonly found in the intestinal flora of 
farm animals as well as healthy people but carriage of VRE in farm animals and 
healthy people was absent in the USA until 2008 (Bonten et al., 2001). This 
difference was ascribed to the widespread agricultural use of avoparcin, which is 
a glycopeptide used in Europe since the 1970s but was never approved for use in 
the USA in agriculture. The problem in Europe was addressed through the 
prohibition on the utilization of avoparcin in 1997 and other antimicrobials as 
growth promoters in animal feed. By contrast, in the USA, selection for 
vancomycin resistance was later discovered to be primarily due to human-to-
human transmission in hospitals; therefore, control had to be conducted 
differently. Avoparcin, which confers cross-resistance to vancomycin, has been 
shown to select for VRE in animals (Aarestrup et al., 1996). A large reservoir of 
VRE in animals presents many opportunities for human infection and the 
potential for resistant bacteria to colonize the human niche. Molecular 
epidemiologic studies have also provided strong evidence on the possibility of 
human to animal transmission and vice versa (Woodford, 2009; Freitas et al., 
2011). 
 
1.1.3 The role of commensals as reservoirs of antimicrobial resistance 
One of the pitfalls of controlling AMR for many decades stems from the 
hidden role of commensals in the emergence, amplification, dissemination and 
maintenance of AMR genes. It is only recently that this phenomenon has been 
uncovered. In various studies, molecular characterization of multidrug-resistant 
commensal E. coli has revealed considerable gene diversity, thereby highlighting 
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the importance of E. coli strains as reservoirs of a wide array of transferable 
genetic determinants (Karczmarczyk et al., 2011; Schink et al., 2011). While 
commensal bacteria may be a hidden reservoir of AMR genes, which can serve as 
an early and potent more accurate indicators of the resistance status of the 
microbiota, dominant AMR carriers vary among ecosystems, antimicrobials and 
even the specific AMR genes within the same host or environmental microbiota 
(Feßler et al., 2011). For instance, in fermented milk, the main AMR gene 
carriers are lactic acid bacteria and in infants, Staphylococcus, not E. coli was 
found to be the primary commensal in the gastrointestinal tract shortly after 
birth (Wang et al., 2006). Aside from their role as transmitters of resistance 
genes to potentially pathogenic bacterial species under certain resistance 
conditions or changes in microbial niches, the non-pathogenic commensal 
bacteria may pick up the status of pathogens (Miskinyte et al., 2013).This could 
happen through horizontal gene transfer of virulence genes, which could co-
occur with resistance genes (Shan Lu et al., 2016), and these genes could be 
translocated into the recipient bacterial chromosome and transmitted vertically 
through to the progeny. Secondly, it could happen through colonization of new 
environments, e.g. intestinal commensal E. coli could colonise the urinary tract 
or the blood system stream (Miskinyte et al., 2013). Thirdly, it may occur 
through the reprogramming of cellular transcription without genetic changes by 
upregulation of virulence genes (Koli et al., 2011). This phenomenon is apparent 
in quorum sensing in which gram-negative and gram-positive bacteria co-
ordinate communal behaviour that involves regulation of specific genes in 
response to population density in which certain chemical compounds (signal 
molecules called autoinducers) accumulate in the cell of the bacteria with 
increase in bacteria population. This activates the transcription of quorum-
sensing-regulated genes (Eboigbodin, et al., 2006; Henke and Bassler, 2004). The 
phenomenon is also employed in AMR resistance in which genes that code for 
efflux pumps are over expressed to enable the pumping out of antimicrobials 
(Pearson et al., 1999; Soto, 2013).The two systems also play a role on 
antimicrobial resistance in gram-positive bacteria (Singh and Ray, 2014)  
 
The acquisition of AMR genes in commensals may occur through horizontal 
gene transfer or selective pressure because of consistent use of antimicrobials in 
animal production and this may create therapeutic problems. Some of the genes 
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acquired by commensal bacteria are thought to co-select for other resistance 
against other types of drugs. For instance, tetracycline resistance genes have 
been found to be associated with other types of resistance genes including 
extended β-lactamase resistance genes (Hammerum and Heuer, 2009). 
Reservoirs of resistance may be present in healthy humans and animals 
(Choudhury et al., 2012). E. coli as a commensal bacterium is found in the 
digestive system of most animals (e.g. poultry, cattle, dogs) (Caudell et al. 
2018) and can contaminate food products during slaughter or food handling and 
subsequently increase the risk of ingestion of AMR bacteria by humans. 
According to van den Bogaard et al. (2001), three isolates of AMR E. coli found in 
contaminated turkey meat belonged to identical types as isolates from turkey 
faeces. Results from an experimental study demonstrated that it is possible for 
antimicrobial-resistant E. coli strains of animal origin to establish as part of the 
flora of healthy human after being ingested (Linton et al., 1977). Different 
animal model studies have also demonstrated that the intestine is a hot spot for 
horizontal transfer of resistance genes between E. coli (Jacobsen et al., 2007; 
Wang et al., 2006). There was a study which detected the same AMR genes in 
animals, meat and in humans, suggesting horizontal transfer (Overdevest et al., 
2011; Silva et al., 2012). Hart et al. (2006) used a chicken and mouse intestine 
model to detect the transfer of a tetracycline resistance gene from E. coli of 
animal origin to E. coli of human origin. As an important and ubiquitous 
commensal in the enteric system of chicken, this study intends to screen for the 
prevalence of AMR in commensal E. coli obtained from chicken cloacal samples. 
This is fundamentally based on the possibility of commensal E. coli being a 
source of resistance genes that could be transferred to other species that are 
pathogenic to humans. 
 
Currently, in Tanzania there is no study that has investigated the 
prevalence of AMR in commensal E. coli across all poultry meat production 
systems. Existing studies in Tanzania have either investigated prevalence of 
resistant bacteria in one type of poultry farm (e.g. extensive poultry systems) or 
compared between two poultry systems (e.g. broiler and extensive systems). 
Comparison of resistance patterns and prevalence across multiple regions and 
production systems (See sections 2.1 and 2.2.2 for details) is pertinent to gaining 
a deeper understanding as to whether geographical differences and an 
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intensification of poultry production could have an impact on AMR patterns and 
prevalence. By analysing resistance profiles of E. coli isolates across the four 
farm types, we may find relevant associations that can lead to a further 
understanding of the epidemiology of resistant bacteria (Harwood et al., 2000) 
and hence allow appropriate interventions to be carried out. In short, this study 
has as a main goal of contributing to a better understanding of carriage of 
antimicrobial resistant E. coli in chickens in the four poultry production systems, 
a phenomenon which could have an implication for public health risks associated 
with consumption of poultry meat or direct contact with the animals. 
 
1.1.4 Antimicrobial susceptibility testing 
Antimicrobial susceptibility testing (AST) is normally conducted to 
determine if bacteria are resistant or not. There are two major ways in which 
this can be conducted, i.e. using phenotypic methods or genotypic methods. 
Whether or not genotypic methods are superior to phenotypic methods is 
debatable (Cockerill, 1999). There are several potential advantages of 
genotyping over phenotyping, e.g. when organisms under study are slow 
growers. Some organisms cannot be cultured or are not easily cultured and so 
only genotypes can be determined in these cases (Cockerill, 1999). On the other 
hand, the resistance of a microorganism to a specific microbial agent may occur 
via different mechanisms associated with different resistance genes or a large 
array of single or coincidental mutations. With genetic methods one only gets 
what they are specifically looking for. This is in contrast to culture-based 
methods which are more comprehensive in assessing antimicrobial resistance. By 
using the same culture-based assay, different forms of resistance can be 
detected. Due to their capacity to survey different forms of resistance, culture-
based methods are also helpful for detecting emerging or new forms of 
antimicrobial resistance (Cockerill, 1999). Genetic methods may detect 
resistance genotypes that are expressed at levels that may not be clinically 
relevant. Examples of this include lower level vancomycin resistance encoded by 
van genes (i.e. vanB and vanC) and poorly expressed extended spectrum β 
lactamase resistance (Cockerill, 1999). The focus of this study will be directed 
towards phenotypic methods.  
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1.1.5 The breakpoint AST technique and Individual Isolate assays 
For the past few decades, phenotypic methods have been the 
predominant methods used for screening and monitoring resistance in bacteria 
populations. Given that these methods are cheap and readily available, they 
have a widely been used in clinical settings in routine tests, both in developed 
and low-income countries. As of late, many epidemiologists have taken a keen 
interest in AMR. Scientists in this field developed a new method that focuses on 
screening populations of bacteria, whereas clinical scientists prefer traditional 
individual isolate screening methods. The population-focused method is a 
breakpoint method. It is an abbreviated form of agar dilution procedure 
(Piddock, 1990). This method is now gaining popularity among epidemiologist 
and has been used by some researchers in Tanzania (Rugumisa et al., 2016; 
Lyimo et al., 2016). Like the conventional individual isolate assays, this method 
utilizes breakpoint concentrations that are set up based on microbiological data. 
In this method the antimicrobial is added to or integrated into the agar at a 
specific breakpoint concentration. Growth on the plate is compared to growth 
on an antimicrobial-free control (Piddock, 1990). No growth indicates presence 
of susceptible strains and growth indicates presence of resistant strains. The 
advantage of this method over individual isolates assays is that it evaluates a 
huge number of microorganisms within a sample at a once while the individual 
isolates assay requires selecting only a few isolates which may or may not 
represent an entire population of microorganisms in a sample. The individual 
isolate assays have the advantage of assessing the resistance of a single isolate 
against several antimicrobials on one plate while the breakpoint method requires 
inclusion of just one antimicrobial in a media at any given time.  For instance, in 
disc diffusion testing six or more different antimicrobials can be tested against 
an organism in one petri dish (Piddock, 1990).  
 
1.1.6 Individual isolate assays for susceptibility testing 
Some of the most common and widely recognised assays for AST of 
individual isolates are the disc diffusion test on agar and microdilution methods 
in liquid media (Piddock, 1990). These methods will be further discussed in 
Chapter 3. 
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1.1.7 Background on interpretive breakpoints 
Breakpoints were initially set up to guide therapy (Kronvall et al., 2011). 
They had to evolve to try and satisfy both the need to guide therapy and the 
need to detect biological resistance. Moreover, due to a lack of harmonisation of 
breakpoints between different countries and within the same country, AST 
methods had to go through major phases of development including setting up 
appropriate breakpoints that can help in objectively determining resistant 
organisms (Kronvall et al., 2011). Minimum inhibitory concentration (MIC) 
breakpoints for microbroth dilution assays were formed based on various aspects 
including pharmacokinetics and microbiological data. These MIC were then 
translated into zone diameter breakpoints for agar-based assays using the 
regression line between MIC values and inhibition zone diameters based on 
multiple bacterial species  (Turnidge and  Paterson, 2007). The calculated zone 
diameter breakpoints for an antimicrobial agent were intended for use 
irrespective of bacterial species. The two major standards were CLSI and 
EUCAST.  The method was improved by the introduction of the use of the error 
rate bound method of Metzler and DeHaan (1974). Subsequent studies suggested 
that interpretation criteria should be species-specific for improved accuracy 
(O’Brien et al., 1977). Chapter 3 discusses the use of different breakpoints to 
determine resistance of individual isolates. 
 
1.2 Research Objectives 
Two major objectives of this study include; 
1. To determine the prevalence of antimicrobial resistant coliforms across 
four poultry production systems in Arusha and Moshi. 
2. To determine the prevalence of AMR E. coli isolates using clinical 
breakpoints and epidemiological cut-off value methods. 
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CHAPTER TWO 
 
PREVALENCE OF ANTIMICROBIAL RESISTANT COLIFORMS IN POULTRY CLOACAL 
SAMPLES ACROSS FARM TYPES IN MOSHI AND ARUSHA DISTRICTS 
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2.1 Introduction 
Poultry, especially chickens, are the most commonly kept and most 
numerous livestock species in the world (Perry, 2002; Morek et al., 2010) 
Backyard chickens are widely distributed in rural and peri-urban areas where 
they play important roles in income generation, food production and social 
interactions (Minga et al., 2001; Thornton, 2002; Morek, 2010). In Tanzania, the 
per capita consumption of poultry meat is estimated at about 15 kg per annum 
(Tanzania Country Brief, 2016). It accounts for about 25% of the meat demand. 
Backyard chickens make up over 70% of the total chicken population and supply 
the vast majority of the poultry meat and eggs for residential markets 
(Covarrubias et al., 2012). In 2016, the chicken population in Tanzania consisted 
of 69 million birds, of which 37 million were backyard and the remaining 32 
million were commercial, including 24 million broilers and 8 million layers 
(Tanzania Country Brief, 2016). Poultry production for commercial purposes is 
mostly practised in urban and peri-urban areas. The Tanzania National Panel 
Survey (NPS) of 2008 - 2009 showed that only 10% of rural farm households are 
market oriented (i.e. sell more than 50% of their produce (Covarrubias et al., 
2012) but consumption patterns are changing and production systems are 
becoming more intensive (Sindiyo et al., 2018; Wilson, 2015). 
 
In Tanzania, chickens are reared under different production systems, 
some of which involve scavenging (free-range and semi-intensive systems), 
intensive systems which mainly involve indigenous breeds and broilers, which are 
imported meat-specific breeds (Sindiyo et al., 2018). The free-range system 
(also referred to as extensive) is the dominant system in most rural areas and 
has been practised for many years (Sonaiya, 1990; Kitalyi, 1998). It requires 
minimal resource input and is generally considered secondary to other 
agricultural activities by farmers. This type of production has many limitations, 
including high disease prevalence, exposure to predators, poor nutrition and 
poor growth rate (Mwalusanya et al., 2002; Mutayoba et al., 2012; Goromela et 
al., 2006). The birds are owned mostly by women and children for home 
consumption, small cash income, social and cultural activities. Birds are left to 
scavenge around the homesteads during the day, feeding on household leftovers, 
waste products as well as insects, worms, seeds and plants. The birds are not 
regularly provided with water and other inputs such as supplementary feeds, 
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housing or treatment (Goromela et al., 2006). In semi-intensive systems, birds 
are partially confined within enclosures made from local materials, in overnight 
shelters or in fenced yards (Sonaiya, 1990). In this system, there is a regular 
provision of water, grains and household wastes, vaccination but little 
medication to control disease and parasites. There may be exchange of 
cockerels between the farms (Sonaiya, 1990; Goromela et al., 2006). Because of 
better management, compared to free range systems, mortality is less and there 
is greater egg production (50 to 150 per hen per year) and higher growth rates 
(10 to 20 gram/day) (Goromela et al., 2006). Products are used for home 
consumption, family cash income and as a source of micro-credit. 
 
Confined systems (intensive) with indigenous chickens are operated by 
some families, particularly those living in peri-urban and urban areas where 
there are markets for eggs and meat, while broiler systems are mostly businesses 
rather than family-run operations. Broiler farmers rear imported breeds 
predominantly for meat production. The choice of production system depends on 
the availability of resources and inputs needed for a particular production 
system (Guèye, 2000). Intensive and broiler poultry keepers are more likely to 
use the recommended standard practices such as appropriate housing, feeding, 
and disease control programmes, and yield around 250 to 300 eggs per hen per 
year and growth rates of 50 to 55 grams/day (Sonaiya, 1990).  
 
The wide use of antimicrobials in poultry production to control and 
manage disease in chickens, particularly in semi-intensive, intensive and broiler 
systems may select for antimicrobial resistant commensal organisms in chickens. 
Faecal E. coli is often considered as a good indicator for selection pressure 
imposed by an antimicrobial use and it is common in the chicken intestine 
(Alekshun and Levy, 2006). This study, therefore, investigates the prevalence of 
AMR in coliforms in extensive, semi-intensive, intensive and broiler farm types, 
focusing particularly on AMR profiles in commensal E. coli using phenotypic 
methods coupled with species confirmation using uidA PCR. E. coli is the 
organism of choice because it can easily acquire AMR when exposed to 
antimicrobial agents. In addition, E. coli can be found in almost all ecological 
niches and are important human, environmental and animal reservoir of AMR 
genes. E. coli is also capable of transferring these resistance genes to other 
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bacteria, including pathogenic bacteria. Consequently, E. coli is of substantial 
clinical importance in both human and veterinary medicine (Agersø et al., 2014). 
 
2.2 Materials and methods 
2.2.1 Study locations 
The study was conducted in urban Arusha and Moshi districts (Figure 2.1). 
The two urban districts were selected because of the presence of the four 
production systems of interest: extensive, semi-intensive, intensive and broiler. 
Arusha urban district (or Arusha City Council) is one of the seven districts of the 
Arusha region of Tanzania and contains the district and economic capital. Moshi 
urban is one of the seven districts of the Kilimanjaro region of Tanzania and 
contains the regional capital, Moshi.  
 
Figure 2.1 Map of Africa (bottom right), showing location of Tanzania (top right), including 
Arusha urban district (top left) and Moshi urban district (bottom left). Location of the study 
farms is marked with symbols and dots (top left) and green dots (bottom left). Source: Map of 
United Republic of Tanzania (2014) and map of Africa (2016) from 
http://thefutureofeuropes.wikia.com (maps allowed for public use). Site accessed on 
30/8/2018. Map of Arusha reproduced from Sindiyo et al. (2018). 
Study sites  
Moshi urban study area   
Arusha urban study area Study sites  
Mo hi urb n study area   
Arusha urban study area 
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2.2.2 Categorization of farming systems 
Farm types were categorised using the following criteria: type of chicken; 
supplementation of feed; degree of confinement of the chickens; use of 
veterinary services; use of labour; flock size and number of poultry houses. Farm 
types are described below with examples shown in Figure 2.2. 
 
2.2.2.1 Extensive systems  
Extensive systems were characterised by indigenous chickens kept under 
free-range conditions. Chickens obtained food through scavenging around the 
homestead. These systems involved little input in terms of management time, 
provision of water, feeding, housing and disease control. Natural breeding was 
common on the farm. Flock sizes ranged from 5 to 50 birds. 
 
2.2.2.2 Semi-intensive systems  
Semi-intensive systems were characterised by indigenous chickens mostly 
contained in enclosed facilities, but also, at some point during the day, released 
to scavenge. Thus, the system involved partial confinement of the birds. 
Supplementary feeding was involved, for example via provision of kitchen waste 
containing remnants of household meals such as bananas or cassava. In addition, 
commercial supplements were regularly incorporated into feed that was mixed 
by farmers on site from independently bought ingredients. Veterinary services 
were provided when necessary. Flock sizes ranged from 50 to 200 birds. 
 
2.2.2.3 Intensive systems  
Intensive systems were characterised as being high-input urban and peri-
urban commercial systems in which indigenous chickens were reared for meat 
and egg production. Crossing of local breeds was common practice in order to 
improve the yield of poultry products (meat and eggs). Feed and feed 
supplements were provided. Farms obtained feed and foundation stocks from 
large-scale commercial poultry farms. Chickens were confined full time in 
constructed facilities. The system involved the use of veterinary services for 
prevention and management of disease and involved full-time labour. Flock sizes 
ranged from 50 to 1000 birds. 
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2.2.2.4 Broiler systems 
Broiler operations were characterised by the use of imported broiler 
breeds and focused exclusively on meat production. Crossing was done regularly 
to enhance the breeds and ensure a high production of poultry meat. Broiler 
systems comprised highly intensified units in which chickens were confined full 
time in constructed facilities. As for the intensive systems, broiler systems 
involved the use of commercial feeds, supplements and extensive use of 
veterinary services. The system invested in full-time labour and the flock sizes 
exceeded 200 birds. 
 
 
Figure 2.2 Examples of poultry production systems in the northern zone of Tanzania (pictures 
taken during field work): intensive broiler (top left); semi-intensive (top right); intensive 
indigenous (bottom left) and extensive (bottom right). 
 
2.2.3 Selection of wards and farms 
A list of administrative wards containing 25 and 21 wards for Arusha and 
Moshi, were obtained from the Arusha and Moshi municipal councils, 
respectively. Subsets of wards containing all four production systems were 
identified, resulting in 18 wards for Arusha and 12 wards for Moshi. Ten wards 
for each district were then randomly selected from these subsets. The selection 
was done by writing the name of each of the 18 wards in Arusha and 12 wards in 
Moshi on pieces of paper and folding to avoid disclosure and prevent bias during 
selection. Separately for Moshi and Arusha, the pieces of paper were randomised 
by tossing in a bowl. Then, five individuals each picked a piece of paper from 
the bowl without replacement. This procedure was done independently for Moshi 
and Arusha and repeated to generate a final list of 10 wards for each district. 
Ward locations and farm locations are shown in Figure 2.1. 
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2.2.4 Study design and sample size 
A cross-sectional study was conducted in which a target number of 100 
cloacal swabs would be collected from per farm type (n = 4) per district (n = 2), 
or 800 samples in total. Use of 100 samples allows for estimation of prevalence 
of 50% (worst case scenario for sample size calculation, for any lower or higher 
prevalence the number of samples needed would be smaller) with a confidence 
level of 95% and precision of 10%. The confidence level is described as “the 
probability of accepting the null hypothesis when it is true” and the precision of 
the estimate (or acceptable error in the estimate) is described as “half the 
width of the desired confidence interval”. The confidence interval is the interval 
around a parameter estimate (here: the prevalence), such that “if an 
experiment was repeated an infinite number of times, the interval generated 
would contain the true value of the parameter in the proportion of trials set as 
confidence level” (here: 95%) (http://epitools.ausvet.com.au/). Per production 
system, one farm was selected (randomly or purposively) in each ward, followed 
by a convenience sampling of 10 birds in each of the farms. Random selection 
was conducted if there were more than 10 farms of a specific production system 
in a given ward. Each sampling day involved visiting a single ward and sampling 
chickens from farms in all four production systems. 
 
The selection of chickens in non-intensive production systems (i.e. 
extensive and semi-intensive) was conducted without regard to the age of 
chicken, whereas in intensive production systems (i.e. intensive and broiler 
systems) the selection of chickens depended on how chickens were sorted in 
their cages by age. For instance, the majority of farms would separate chickens 
with an age gap of two weeks into different cages. To maximise diversity in our 
selection, we chose cages corresponding to different ages and randomly picked 3 
chickens from each cage (making 9 samples) and then selecting the 10th chicken 
to be sampled arbitrarily from any cage.  
 
2.2.5 Collection and laboratory handling of cloacal swabs 
Cloacal swabs were collected using Amies swabs (MML Diagnostics, 
Troutdale, OR). The process involved inserting a swab into the cloaca of the 
chickens and gently swabbing the mucosal wall taking any fluid or faecal 
material around the cloaca (Figure 2.3). The swabs (Figure 2.4) were transported 
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in ice packed cool boxes to the Kilimanjaro Clinical Research Institute (KCRI) 
where they were stored at –80 ºC in 1000 µl mixture of 85% Brain Heart Infusion 
and 15% glycerol.  
 
 
Figure 2.3 From left to right, poultry cloacal sample collection, labelling, temporary storage in 
cooler boxes and shipment to the zoonosis laboratory at Kilimanjaro Clinical Research Institute. 
 
 
 
Figure 2.4 Poultry cloacal swab in a transport media (Amies swab) 
 
2.2.6 Laboratory procedures for isolation and enumeration of coliforms on 
MacConkey agar 
Screening was conducted to identify and enumerate the overall coliform 
population and resistant coliforms contained in cloacal samples using MacConkey 
agar with or without antimicrobials, respectively, using a modified breakpoint 
plate protocol based on Caudell et al. (2018). MacConkey agar as a selective and 
differential medium contained bile salts and crystal violet that selectively inhibit 
the growth of gram-positive bacteria such as S. aureus, whilst lactose and a 
neutral red indicator in the medium allowed the differentiation of gram-negative 
bacteria based on lactose fermentation. Coliforms are generally capable of 
fermenting lactose and producing acid, forming pink to red colonies, whilst 
other gram-negative bacteria such as Salmonella, Shigella and Pseudomonas spp. 
are incapable of fermenting lactose, leading to the formation of white colonies. 
Antimicrobial susceptibility breakpoint assays were used to identify coliforms 
that were resistant to particular antimicrobial compounds at specific 
concentrations (as described below) in accordance with CLSI standards.  
 
Media preparation of MacConkey agar (Oxoid Thermofisher, Basingstoke, 
UK) was conducted by suspending approximately 50 grams of dehydrated media 
22 
 
in 1000 ml purified/distilled water and heating to boiling point to dissolve the 
media completely. The dissolved media was sterilized by autoclaving at 15 lbs 
pressure (121 °C) for 15 minutes and cooled to 45 - 50 °C. Working stocks of the 
antimicrobials were prepared at specific concentrations (tetracycline (16 
µg/ml), ciprofloxacin (4 µg/ml), ceftazidime (8 µg/ml) and imipenem (4 µg/ml)) 
and mixed well with cooled but still liquid media before pouring into sterile 
petri plates (Greiner Bio-One, cat. no. 662160).  
 
The cloacal swab samples, which were stored in a mixture of Brain Heart 
Infusion (BHI) (Thermo Fisher Scientific Inc., Ottawa, ON, Canada), were thawed 
at 2 °C overnight. Samples were homogenised and a volume of 50 µl was 
aliquoted and mixed with 450 µl of maximum recover diluent (MRD) (Oxoid 
Thermofisher, Basingstoke, UK), and vortexed. The mixture was plated using a 
spiral plater (Spiral System, Inc. Cincinnati, Ohio) which was set to dispense 50 
µl of the mixture in a logarithmic dilution on plain MacConkey, as well as onto 
MacConkey plates with antimicrobials. Briefly, this method involved inoculation 
of the liquid sample on a rotating MacConkey agar with the spiral plater. The 
volume of the cloacal sample suspension was dispensed as the dispensing stylus 
moved from the centre to the edge of the rotating plate. This was followed by 
incubation at 37 ± 3 °C overnight.  
 
Lactose fermenting colonies were identified as pink colonies (Caudell et 
al., 2018) on the media (Figure 2.5) and assumed to be coliforms (E. coli, 
Klebsiella spp., Enterobacter spp. and Citrobacter spp.), even though 
exceptions to that classification may exist. Colonies that appeared yellow or 
white were not enumerated. Coliforms that grew on MacConkey plates with 
antimicrobials were considered resistant. After incubation, enumeration of 
coliforms was conducted on plain MacConkey agar and MacConkey agar with 
antimicrobials using the spiral plater grid method that has been standardised for 
use at KCRI. The method involved placing a grid on each plate, positioned on a 
level surface and adjusted so that the centre of each grid matched that of the 
plate on the viewer. This position was maintained while counting colonies. The 
grid was divided into segments in which colonies were enumerated from the 
outer edge of the segment toward the centre allowing the corresponding 
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microbial concentration (bacterial count/ml) on the whole plate to be estimated 
according to the KCRI standardized protocol. 
 
2.2.7 Collection and storage of plate sweeps 
Sweeps of bacteria were taken from plain MacConkey agar plates and 
archived at -80 ºC. Aliquots of the plate sweeps were later prepared for 
shipment to Glasgow where further analysis was conducted. Plate sweeps were 
only collected if a plate contained pink colonies, i.e. presumed coliforms. In 
brief, the process involved demarcating the plate into two segments using a 
marker on the lower surface of the plate. Through the use of cotton swabs, 
sweeps were taken from one segment by placing the cotton swab at the centre 
of the plate where growth was most concentrated and then carefully dragging 
while rolling the swab across the surface towards the edge of the plate. Two 
vials of plate sweeps were taken from each plate. One vial was archived and the 
other was stored for shipment to Glasgow. Swabs were stored in tubes 
containing 15% glycerol mixed with MRD media, organised in cardboard boxes 
and stored at -80 ºC. Plates sweeps were shipped frozen on dry ice to the One 
Health Research in Bacterial Infectious Diseases (OHRBID) laboratory at Glasgow 
University where further work was conducted as detailed below. 
 
2.2.8 Additional testing in Glasgow 
Further work in Glasgow was conducted to assess whether results found in 
Tanzania based on the breakpoint plate method were reproducible. For this 
process, one sample per farm was selected from each of the 74 farms (of 79 
sampled) on which coliforms were found. 
 
Plate sweeps from the selected samples that were shipped from Tanzania 
and stored in Glasgow at -80 ºC were processed as follows.  The steps involved 
taking 40 µl of the plate sweep and inoculating in Luria-Bertani broth (Oxoid, 
Canada) and then incubating overnight at 37 ºC. The optical density (OD) of the 
resulting broth was measured by adding 100 µl of the culture to a microwell 
plate then measured using a spectrophotometer at 570nm (OD570) and adjusting 
until the desired concentration was reached (i.e. 0.5 MacFarland). From the 
desired broth concentration, serial dilutions from 10-1 to 10-7 of culture 
suspension were prepared on a microwell plate. Per dilution, three drops of 20 
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µl were inoculated on plain MacConkey agar (MAC) and MacConkey agar with a 
breakpoint concentration of tetracycline (TET) (Oxoid Thermofisher, 
Basingstoke, UK) and incubated overnight at 37 ºC. The purpose of the serial 
dilutions was to achieve a concentration at which colony forming units could be 
enumerated on the plates, whereby the ideal number of colonies per drop would 
be between 5 and 50 to allow for accurate enumeration.  
 
In Tanzania, colony counts on breakpoint plates were determined for suspensions 
of cloacal swabs whereas colony counts on breakpoint plates in Glasgow were 
determined for dilutions of plate sweeps that were harvested from MacConkey 
plates in Tanzania. Thus, direct comparison of colony counts was not 
meaningful. As an alternative means of comparison, the ratio of tetracycline 
resistant coliforms to total coliforms was calculated for cloacal swab suspensions 
and plate sweeps as follows: 
Ratio = Log (cfu/ml) on tetracycline plates 
Log (cfu/ml) on plain MacConkey plates 
 
2.2.9 Statistical analysis 
Statistical analysis was conducted using the computing environment (R 
version 3.6.1). A Chi-squared test was used to test the association between 
presence of coliforms and district (i.e. Arusha and Moshi), farm type and 
antimicrobial classes (tetracycline, ciprofloxacin, imipenem and ceftazidime). 
The coefficient of determination (R-squared value) was used to provide the 
proportion of variance in the dependent variable (coliform counts resistant to 
one antimicrobial) explained by the independent variable (coliform counts 
resistant to another antimicrobial). This quantity was used to assess the strength 
of the relationship between counts of coliforms resistant to different pairs of 
antimicrobials. Pearson's correlation coefficient was used to assess correlation 
between the proportions of tetracycline resistant isolates derived in Tanzania 
and Glasgow. Distributions of counts were compared between groups (farm type, 
district, and antimicrobial type) using the Kruskall-Wallis test and medians were 
compared using the Mann-Whitney U Test. 
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2.3 Results 
2.3.1 Prevalence of coliforms 
Out of 800 target samples, 746 cloacal swabs were collected (Table 2.1). 
This was fewer than planned because some farms lacked a sufficient number of 
chickens to sample 10 chickens per farm. In addition, cloacal samples were 
collected from only 19 extensive farms in Moshi and Arusha urban districts, out 
of 20 target farms, as one farm could not be sampled at the time of sample 
collection. Thus, samples were collected from 79 of the 80 farms visited. Of the 
746 samples that were collected, 648 (86.8%) contained coliforms (Table 2.1) 
corresponding to 74 of the 79 sampled farms. There was no significant difference 
in the overall prevalence of coliforms between Moshi (86.4 %) and Arusha 
districts (87.3%) (Chi-squared = 0.060, df = 1, p-value = 0.81).  
 
 
Figure 2.5 Growth on MacConkey agar. Pink colonies (lactose fermenters) were considered to be 
coliforms. 
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Table 2.1 Number of cloacal swab samples positive for coliforms (% in brackets) across four farm 
types in Arusha and Moshi districts in Northern Tanzania.  
District Farm 
type  
typetypes 
                       Number of samples 
    Coliforms absent Coliforms present Total 
Arusha Extensive 19 (22.6) 65 (77.4) 84 
  Semi Int. 11 (12.4) 78 (87.6) 89  
Intensive 16 (17.8) 74 (82.2) 90 
  Broiler 2 (2.2) 88 (97.8) 90  
Total 48 (13.6) 305 (86.4) 353      
Moshi Extensive 11 (11.1) 88 (88.9) 99  
  Semi Int. 12 (12.1) 87 (87.9) 99  
  Intensive 21 (21.9) 75 (78.1) 96  
  Broiler 6 (6.1) 93 (93.9) 99  
  Total 50 (12.7) 343 (87.3) 393      
Combined Extensive 30 (16.4) 153 (83.6) 183   
Semi Int. 23 (12.2) 165 (87.8) 188   
Intensive 37 (19.9) 149 (80.1) 186   
Broiler 8 (4.23) 181 (95.8) 189   
Total 98 (13.1) 648 (86.9) 746 
 
 
There was a difference between farm types in the prevalence of coliforms 
within the Arusha district (Chi-squared = 17.19, df = 3, p-value < 0.001) and 
within the Moshi district (Chi-squared = 11.46, df = 3, p-value < 0.01), but no 
consistent pattern in the prevalence across the farm types could be observed in 
either district. However, combining data across districts and across non-broiler 
farmers, showed that broiler farms had significantly higher prevalence of 
coliforms (95.8%) than the other farm types combined (83.8%) (Chi-squared = 
16.56, df = 1, p-value < 0.0001). Between districts, the extensive farm types 
showed the greatest difference (of almost 11.5%), but this difference was not 
statistically significant (Chi-squared = 3.5914, df = 1, p-value = 0.058).  
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2.3.2 Distribution of presence of resistant coliforms by antimicrobial type 
 
Table 2.2 Number of cloacal samples (% in brackets) positive for antimicrobial resistant coliforms by antimicrobial and farm type in Arusha and Moshi districts. 
District Farm type Tetracycline Total Ciprofloxacin Total Imipenem Total Ceftazidime Total 
    Yes No   Yes No   Yes No   Yes No   
Arusha Extensive 59 (90.8) 6 (9.2) 65 40 (61.5) 25 (38.5) 65 39 (60) 26 (40) 65 50 (76.9) 15 (23.1) 65 
  Semi Int. 73 (93.6) 5 (6.4) 78 38 (48.7) 40 (51.3) 78 54 (69.2) 24 (30.7) 78 63 (80.8) 15 (19.2) 78 
 
Intensive 72 (97.3) 2 (2.7) 74 55 (74.3) 19 (25.6) 74 63 (85.1) 11 (14.9) 74 65 (87.8) 9 (12.2) 74 
  Broiler 87 (98.9) 1 (1.1) 88 80 (90.9) 8 (9.1) 88 60 (68.2) 28 (31.8) 88 78 (88.6) 10 (11.4) 88 
                            
Moshi Extensive 82 (93.2) 6 (6.8) 88 41 (46.6) 47 (53.4) 88 63 (71.6) 25 (28.4) 88 71 (80.7) 17 (19.3) 88 
  Semi Int. 84 (96.6) 3 (3.4) 87 75 (86.2) 12 (13.8) 87 79 (90.8) 8 (9.2) 87 81 (93.1) 6 (6.9) 87 
  Intensive 69 (92) 6 (8) 75 53 (70.7) 22 (29.3) 75 57 (76) 18 (24) 75 59 (78.7) 16 (21.3) 75 
  Broiler 90 (96.8) 3 (3.2) 93 82 (88.2) 11 (11.8) 93 68 (73.1) 25 (26.9) 93 79 (84.9) 14 (15.1) 93 
  Total 616 (95.0)   648 464 (71.6)   648 483 (74.5)   648 546 (84.3)   648 
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The total number of samples containing resistant coliforms is summarized 
by region and by farm type in Table 2.2 whilst the variation in prevalence at 
farm type level is shown in Figure 2.6. Resistance to each of the four 
antimicrobial types was detected at least once in every extensive farm and 
every broiler farm, and in 18 of 19 semi-intensive and intensive farms. Neither 
district had a consistently higher prevalence of resistance. The prevalence of 
tetracycline resistance across all farm types (95.0%) was higher than the 
prevalence of resistance to other antimicrobial types (71.6% had ciprofloxacin 
resistant coliforms; 74.5% had imipenem resistant coliforms and 84.3% had 
ceftazidime resistant coliforms), and a significant difference between the 
resistant proportions (Chi-squared = 144, df = 3, p-value < 0.0001) was found. 
Similar patterns were seen within each district with significant differences 
between the overall proportions of resistance to each antimicrobial type in 
Arusha (Chi-squared = 84.0, df = 3, p-value < 0.001) and Moshi (Chi-squared = 
62.7, df = 3, p-value < 0.001) and in both districts the prevalence of resistance 
to tetracycline was greater than the prevalence of resistance to the other 
antimicrobial types. 
 
There was no consistent increase or decrease in prevalence of resistant 
coliforms with intensification of farm types (Table 2.2; Figure 2.6). Prevalence 
of tetracycline resistance was generally high across all farm types. Within any 
given farm type and district, the prevalence of tetracycline resistance was 
higher than the prevalence of resistance to any other antimicrobial type. 
However, there were differences in prevalence of resistance across farm type 
for antimicrobials other than tetracycline. In Arusha, there were significant 
differences between farm types for ciprofloxacin (Chi-squared = 37.9, df = 3, p-
value < 0.001) and imipenem (Chi-squared = 11.4, df = 3, p-value < 0.01) and in 
Moshi for ciprofloxacin (Chi-squared = 50.1, df = 3, p-value < 0.001), imipenem 
(Chi-squared = 11.8, df = 3, p-value < 0.01) and ceftazidime (Chi-squared = 7.88, 
df = 3, p-value = 0.049). There is evidence of an interaction between farm type 
and district for prevalence of ciprofloxacin resistant coliforms (Figure 2.6), i.e.  
a decrease with intensification in Arusha (with the exception of broiler farms) 
and an increase with intensification in Moshi. 
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There were no consistent effects of district on the distribution of 
resistance. The prevalence of imipenem resistant coliforms appears higher in 
Moshi although the difference is only significant for the semi-intensive farms 
(Chi-squared = 10.9, df = 1, p-value < 0.001) whilst no effect of district was seen 
on the prevalence of tetracycline (Chi-squared = 0.042, df = 1, p-value = 0.84), 
ciprofloxacin (Chi-squared = 0.73, df = 1, p-value = 0.39) and ceftazidime (Chi-
squared = 0.01, df = 1, p-value = 0.92) resistant coliforms. 
 
 
Figure 2.6 Distribution of farm-level prevalence of resistant coliforms in poultry cloacal swabs (n 
= 648) where up to 10 samples were taken per farm per production system in Moshi district 
(green) and Arusha district (orange) for the four farm types: extensive (1.E), semi- intensive 
(2.S), intensive (3.I) and broiler (4.B) and the four antimicrobial types: tetracycline (TET), 
ciprofloxacin (CIPRO), imipenem (IMI) and ceftazidime (CEFT). 
 
  
30 
 
2.3.3 Distribution of counts of resistant coliform per antimicrobial type 
2.3.3.1 The distribution of antimicrobial resistance per antimicrobial type 
within farm types across two districts in northern Tanzania 
When comparing data between farm types, the lowest median colony counts 
across all farm types are for ciprofloxacin resistant colonies (Figure 2.7). Median 
counts for tetracycline, imipenem and ceftazidime resistant colonies are similar 
across compounds and farm types for the semi-intensive, intensive and broiler 
farm types. The distributions of counts are skewed towards lower counts for 
ciprofloxacin in extensive, intensive and broiler farms, and for ceftazidime in 
extensive farms.  
 
 
Figure 2.7 Violin plot of coliform colony counts on culture positive MacConkey plates containing 
one of four antimicrobial compounds, i.e. tetracycline (TET), ciprofloxacin (CIPRO), imipenem 
(IMI), or ceftazidime (CEFT) and streaked with cloacal swabs from the four farm types: extensive 
(1.E), semi-intensive (2.S), intensive (3.I) and broiler (4.B). Data combined for Arusha and Moshi 
districts. Red dots indicate median values. Red dots indicate median values.  
 
Figure 2.8 shows analysis of the count data by district and includes counts from 
plain MacConkey (total coliforms) as well as the breakpoint plates. The 
distributions of total and resistant coliform counts were clearly bimodal and 
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sometimes trimodal, e.g. counts for total coliforms, tetracycline resistant 
coliforms, imipenem resistant coliforms and ceftazidime resistant coliforms for 
broiler farms in Moshi district. 
 
 
Figure 2.8 Density plots for the total and resistant coliform counts (in log cfu) in cloacal swabs 
for the four types of antimicrobials (tetracycline (TET), ciprofloxacin (CIPRO), imipenem (IMI), 
ceftazidime (CEFT)) per farm type in the Arusha and Moshi urban districts. 1.E = extensive, 2.S = 
semi-intensive, 3.I = intensive, 4.B = broiler. 
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Figure 2.9 Colony counts on culture positive plates containing four antimicrobial types 
(tetracycline (TET), ciprofloxacin (CIPRO), imipenem (IMI), ceftazidime (CEFT)) and streaked 
with cloacal swabs for Arusha district (orange) and Moshi district (green) from the four farm 
types: extensive (1.E), semi-intensive (2.S), intensive (3.I) and broiler (4.B). Red dots indicate 
median values. Each blue or orange dot represents an individual poultry cloacal swab. 
 
The individual counts contributing to the density distributions shown in 
Figure 2.8 are shown explicitly in Figure 2.9. Median counts (in log(cfu) ranged 
from just under 5 to just under 10, with no consistent differences between 
antimicrobial compounds. These patterns could also be observed for individual 
antimicrobial types. In general, there was a significant difference between 
districts for tetracycline (Kruskal-Wallis = 11.2, df = 1, p-value < 0.001), for 
ciprofloxacin (Kruskal- Wallis = 24.3, df = 1, p-value < 0.0001), for imipenem 
(Kruskal - Wallis = 19.5, df = 1, p-value < 0.0001) and for ceftazidime (Kruskal-
Wallis = 8.15, df = 1, p-value < 0.01). 
 
As well as variation between districts, there was variation in the 
distribution of coliform counts across farm types. There was a significant 
difference in the distribution of resistant coliform counts across the four 
antimicrobial types (Kruskal-Wallis = 192, df = 3, p-value < 0.0001). A significant 
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difference was seen in the distribution of coliform counts across all the four 
farm types (Kruskal - Wallis = 43.6, df = 3, p-value < 0.0001). 
 
Most farms exhibited high within-farm variation in coliform counts (Figure 
2.10) although the patterns depended on the antimicrobial types as well as the 
farm identity. Whilst for some farms some antimicrobial types had counts 
centred around the median (e.g. A-I5), others had highly dispersed coliform 
counts (e.g. farm A-I6). There were also farms which only had high counts (e.g. 
M-B10) and farms with only low counts (e.g. A-I8). No consistent patterns or 
differences between farm type or district could be observed.  
 
 
Figure 2.10 Distribution of total coliform counts within farms grouped by farm type (extensive, 
semi- intensive, intensive and broiler) in Arusha and Moshi districts. Each black dot represents a 
cloacal swab (n = 648). Red dots represent the median counts for individual farms (up to 10 
samples per farm).  
 
Distributions of counts for individual birds within farms were also 
examined for each of the breakpoint plates (Figure 2.11 through 2.14). 
Generally, there was high variability in coliform counts within individual farms 
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with a few exceptions. For example, in counts of tetracycline resistant coliforms 
(Figure 2.11), farm M-E1, showed substantial variability while farm A-E3 had 
minimal variability. There were some farm and antimicrobial types for which 
there were only high counts (ciprofloxacin resistant coliforms on farm M-B10, 
Figure 2.12) while other farms contained only low coliform counts (tetracycline 
resistant coliforms on farm A-E3, Figure 2.11). These patterns, however, were 
not consistent between antimicrobial types. Overall, there was significant 
difference in the distribution of resistant coliform counts between individual 
farms for all antimicrobial types; tetracycline (Kruskal-Wallis = 235, df = 73, p-
value < 0.0001), ciprofloxacin (Kruskal-Wallis = 346, df = 73, p-value < 0.0001), 
imipenem (Kruskal-Wallis = 339, df = 73, p-value < 0.0001), ceftazidime (Kruskal-
Wallis = 288, df = 73, p-value < 0.0001). 
 
 
Figure 2.11 Distribution of tetracycline resistant coliform counts within farms grouped by farm 
type (extensive, semi- intensive, intensive and broiler) in Arusha and Moshi districts. Each black 
dot represents a cloacal swab (n = 616). Red dots represent the median counts for individual 
farms (up to 10 samples per farm).  
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Figure 2.12 Distribution of ciprofloxacin resistant coliform counts within farms grouped by farm 
type (extensive, semi- intensive, intensive and broiler) in Arusha and Moshi districts. Each black 
dot represents a cloacal swab (n = 464). Red dots represent the median counts for individual 
farms (up to 10 samples per farm).  
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Figure 2.13 Distribution of imipenem resistant coliform counts within farms grouped by farm type 
(extensive, semi- intensive, intensive and broiler) in Arusha and Moshi districts. Each black dot 
represents a cloacal swab (n = 483). Red dots represent the median counts for individual farms 
(up to 10 samples per farm).  
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Figure 2.14 Distribution of ceftazidime resistant coliform counts within farms grouped by farm 
type (extensive, semi- intensive, intensive and broiler) in Arusha and Moshi districts. Each black 
dot represents a cloacal swab (n = 564). Red dots represent the median counts for individual 
farms (up to 10 samples per farm).  
 
2.3.4 The relationship between counts of coliform resistant to different 
antimicrobial compounds  
The regression lines (Figure 2.15) illustrate the relationship in each cloacal 
sample between the number of colony forming units resistant to each 
antimicrobial pair. The strength of the relationship varies. For example, only 
29% of the variation in coliforms counts resistant to ciprofloxacin could be 
explained by change in the imipenem coliform counts (a weak association) 
whereas 55% of the variation in coliform counts resistant to ceftazidime could be 
explained by a change in the count of tetracycline resistant colonies (a strong 
association). 
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Figure 2.15 The pairwise relationships between coliform counts (data transformed using log(cfu+1) resistant to the four antimicrobial types (tetracycline (TET), 
ciprofloxacin (CIPRO), imipenem (IMI) and ceftazidime (CEFT)) in Arusha and Moshi districts for the four farm types: extensive (1.E), semi- intensive (2.S), intensive 
(3.I) and broiler (4.B). 
Y= 0.63x + 4.5
R2 = 0.40
Y= 0.82x + 4.5
R2 = 0.50 Y= 0.67x + 3.2
R2 = 0.55
TET&CIPRO TET&IMI TET&CEFT
TET Log (cfu+1) TET Log (cfu+1) TET Log (cfu+1)
CI
PR
O
 L
og
 (c
fu
+1
)
IM
I L
og
 (c
fu
+1
)
CE
FT
 L
og
 (c
fu
+1
)
Y= 0.47x + 1.2
R2 = 0.29
Y= 0.56x + 0.73
R2 = 0.38 Y= 0.77x + 1.3R2 = 0.53
CIPRO&IMI CIPRO&CEFT IMI&CEFT
IM
I L
og
 (c
fu
+1
)
CE
FT
 L
og
 (c
fu
+1
)
CE
FT
 L
og
 (c
fu
+1
)
CIPRO Log (cfu+1) CIPRO Log (cfu+1) IMI Log (cfu+1)
39 
 
2.3.5 Growth on plain MacConkey agar and breakpoint agar for plate sweeps 
For the 74 plate sweeps transferred from Tanzania to Glasgow, growth was 
observed on plain MacConkey and tetracycline plates (Figure 2.16) whilst no 
growth was observed on ciprofloxacin, ceftazidime and imipenem plates. 
Therefore, these data were excluded from further analysis and comparisons 
were restricted to tetracycline and plain MacConkey counts. Dilutions that were 
used for analysis on MAC were between 10-4 to 10-7 whilst dilutions that were 
used for analysis on TET plates were between 10-1 to 10-7. 
 
 
 
Figure 2.16 Dilution series of coliforms on plain MacConkey (MAC) and a MacConkey plate with 
breakpoint concentration of tetracycline (TET). Comparison of counts allows determination of 
the proportion of coliforms that is resistant to tetracycline, enabling comparison of data derived 
from plate sweeps with those derived from the original samples.  
  
Direct comparison between count data derived in Tanzania and that in 
Glasgow was not meaningful because the data in Tanzania were obtained from 
the cloacal swab samples whereas the data in Glasgow were obtained from plate 
sweeps. As an alternative, the ratio of the number of tetracycline resistant 
isolates to the number of all coliform isolates was calculated for each sample in 
the Glasgow and Tanzania derived datasets. There was no association the 
between the ratios in the 64 samples (R2 = 0.0385; Figure 2.17).  
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Figure 2.17 The ratio of coliform counts on tetracycline-containing MacConkey breakpoint plates 
to coliform counts on plain MacConkey plates as determined from suspensions of cloacal swabs in 
Tanzania and from plates sweeps from the same swabs that were frozen, shipped and retested in 
Glasgow. 
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2.4 Discussion 
Our findings indicate that chickens can be reservoirs of resistant 
coliforms. Resistance to each of the four antimicrobials was detected at least 
once in every farm on which coliforms were found. No significant difference in 
prevalence of resistant coliforms was seen between Arusha and Moshi districts, 
which may reflect similar antimicrobial use in these districts. These results 
differ from other studies on antimicrobial resistance in this area of Northern 
Tanzania which have found differences in antimicrobial usage patterns and 
resistance levels between the major ethnic groups in these districts (Caudell et 
al., 2017; Caudell et al., 2018). However, the Caudell studies investigated rural 
communities with distinct ethnic groups and livelihoods in each district. Thus, 
the Caudell work encompassed many types of livestock husbandry whereas the 
present study focuses on chicken farming as the livelihood of interest.  
 
The prevalence of tetracycline resistance was consistently higher in all 
farm types in both districts. Unlike the other antimicrobials, tetracycline use is 
quite common (Sindiyo et al., 2018). Both districts have been reported to use 
antimicrobials, particularly tetracycline, for non-therapeutic purposes (i.e. 
prophylaxis and growth promoters) (Caudell et al., 2017; Sindiyo et al., 2018). 
Tetracycline is one of the most ubiquitous antimicrobials used in animal 
production worldwide (Dahshan et al., 2015) especially in low-income countries 
where heavy use is driven by  its accessibility, low price, wide spectrum and 
shelf life. Coupled with its ability to co-select for other resistance, these factors 
all act in favour of widespread tetracycline resistance (Al-Ghamdi et al., 2000; 
Kazuki and Tetsuo, 2010). Other countries have also consistently revealed high 
tetracycline resistance (Fahrenfeld et al., 2014; Tacão et al., 2014; Hamisi et 
al., 2014; Chee-Sanford et al., 2001; Sunde and Norström, 2006). 
 
Although prevalence of resistance to the other antimicrobials was lower 
than for tetracycline, apparent resistance to ceftazidime, imipenem and 
ciprofloxacin was nevertheless very common. Differences in prevalence of 
resistance to these other antimicrobials could potentially be associated with 
variation in usage between farms and farming systems in use of those 
antimicrobials, but data on usage was not collected as part of this study. 
Resistance to imipenem and ceftazidime was not expected as these 
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antimicrobials are not used in poultry production (Sindiyo et al., 2018). 
Reservoirs of cephalosporin resistance were reported in the past in water 
sources (i.e. tap and open water sources) within these same districts (Lyimo et 
al., 2016). Moreover, these water sources are commonly used in poultry 
production (Sindiyo et al., 2018) hence may provide an explanation for the 
presence of cephalosporin resistance in poultry. By contrast, no direct evidence 
to date on imipenem use or resistance in poultry or environmental sources has 
been reported in these districts to help us understand the source of resistance to 
this compound in poultry. When plate sweeps were harvested in Tanzania and 
re-tested in Glasgow, the observations of cephalosporin, ciprofloxacin and 
imipenem resistance could not be reproduced so experimental methods may also 
have contributed to the apparent resistance. Confirmation of the presence of 
AMR based on testing of individual isolates would be desirable, although 
interpretation criteria could still affect prevalence estimates when using such an 
approach (see Chapter 3). 
 
Our study revealed strong correlations (with an R2 exceeding 0.5 in some 
cases) in the number of coliforms resistant to antimicrobial pairs (i.e. 
tetracycline and ceftazidime; tetracycline and imipenem; imipenem and 
ceftazidime). Although this data does not confirm presence of the two types of 
resistance in individual isolates, the high correlation suggests the possibility of 
co-selective pressure between different antimicrobials. This ability is well 
established for tetracycline. This is mostly facilitated  by a co-transfer of 
tetracycline resistance genes along with genes responsible for conferring 
resistance to other types of antimicrobials in the same genetic elements (Al-
Ghamdi et al., 2000; Harada and Asai, 2010; Jong-Mi and Gun-Jo 2015) Further 
investigation is needed to establish whether this phenomenon exists between 
ceftazidime and imipenem.  
 
The distribution of coliform counts not only showed considerable variation 
between samples but also revealed bimodal and trimodal distributions. Various 
studies have attributed bimodal or trimodal distribution of bacterial populations 
to different forms of resistance mechanisms  (Shah et al., 2006; Smith and 
Christofilogiannis, 2007). Bacteria can form separate populations based on 
expression levels of resistance (Mazzariol et al., 2000; Mcmurry et al., 1998). 
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The bimodal distribution could also be attributed to the presence of a varying 
resistance mechanism (Mazzariol et al., 2000). Wistrand-Yuen et al. (2018) 
demonstrated that microorganisms have the capacity of developing different 
mechanisms of resistance when subjected to varying levels of exposure to 
antimicrobials. When exposed to sub-therapeutic levels of antimicrobials, 
microorganisms are capable of evolving novel mechanisms that are different 
from those observed during lethal selection (i.e. treatment). The study also 
showed that that under sub-therapeutic conditions, microorganism can develop 
degrees of resistance in a stepwise process over time through accumulation of 
several resistance mutations, which independently have small effects. There is 
therefore the possibility that poultry in the current study were constantly 
exposed to sub-therapeutic levels of antimicrobials, whether from the 
environment or through direct use of antimicrobials, which may have led to 
differing mechanisms of resistance or levels of resistance within the same 
species, generating the tri or bimodal distributions.  
 
A bimodal distribution can also be caused in certain bacterial populations 
by phenotypic switching between latency (or sometimes slow growth) of 
bacterial cells. This happens when bacteria are subjected to antimicrobial stress 
or other environmental stresses. These slow growing cells are called persister 
cells and it is believed they can maintain this phenotype for a long time (Kussell 
et al., 2005; Balaban et al., 2004). Thus, genetically identical bacterial 
populations can respond heterogeneously to antimicrobial treatment, creating 
multimodal distributions (Radzikowski et al., 2016; Kussell et al., 2005; Balaban 
et al., 2004). However, further investigations need to be conducted to 
determine reasons for this phenomenon in the present study. 
 
There was a striking difference in results obtained in Tanzania compared 
to the results obtained in Glasgow for a selection of 74 samples. First, there was 
loss (7%) of plate sweeps where growth on MacConkey agar was not seen when 
plate sweeps were re-cultured in Glasgow. This may have been due to loss of 
viability during shipping of coliforms. Viability of coliforms can be affected by 
storage at -20 ºC (Schukken et al., 1989) and temperatures in that range may 
have occurred during shipment. Second, no resistance was found to ceftazidime, 
imipenem or ciprofloxacin in the plate sweeps analysed in Glasgow. The 
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subsequent comparisons therefore focused on a comparison of the ratio of 
tetracycline resistant colony counts to total colony counts between the Glasgow 
and Tanzania analysed samples but no correlation was found between the 
proportion of tetracycline resistant colonies in the Glasgow and Tanzania 
analyses. 
 
The observed differences could be due to several various reasons. One is 
the loss of antimicrobial efficiency during shipping of reagents to Tanzania. 
Some antimicrobials such as imipenem are quite sensitive to temperature 
fluctuation. Temperature fluctuations or a breach in the cold chain during 
shipment is quite possible, particularly when ice is used for refrigeration as this 
melts very quickly in hot countries like Tanzania. For instance, the 
recommended storage temperature for imipenem is -70 ºC; once this 
temperature is exceeded and temperature rises above -10 ºC the compound 
losses its efficiency. Loss of quality may also have occurred for ciprofloxacin and 
ceftazidime, leading to the apparent resistance observed in Tanzania, but not in 
Glasgow where quality of reagents would not have been affected by ambient 
temperatures. Control strains should have been included for each compound in 
each testing round. This is common in MIC testing but wasn’t practiced in this 
project when focusing on the breakpoint plate method.  
 
2.5 Conclusion 
Our investigation suggests the widespread presence of resistant coliforms 
in poultry in poultry production systems in two districts in Northern Tanzania. 
Such information is valuable both for poultry farm workers and for the 
community as a whole as it provides information on the potential risk of 
exposure to resistant coliforms. More broadly, this information can help aid 
awareness amongst health professionals and policy makers about the extent to 
which AMR could be entering the food chain. However, our study also highlights 
limitations which led to the lack of reproducibility of results between two 
different laboratories. This study highlights the importance of maintaining 
appropriate temperatures during shipment of reagents as the potency and 
viability of fragile compounds such as imipenem could be affected. Although this 
was not verified in the current study breaks in cold chain could be detrimental 
to the functionality of certain antimicrobials and could cause them to be less 
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effective. Quality control strains with known resistance profiles should be 
included routinely in breakpoint plate investigations.  
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CHAPTER THREE 
 
ANTIMICROBIAL RESISTANCE OF ESCHERICHIA COLI ISOLATES FROM POULTRY 
USING CLINICAL BREAKPOINTS, ECOLOGICAL CUT-OFFS AND NORMALISED 
RESISTANCE INTERPRETATION 
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3.1 Introduction 
AST is based on measurement of the concentration of antimicrobials that 
inhibit bacterial growth. This can be done in two major ways, i.e.  in liquid 
media or on solid media and yields data on minimal inhibitory concentrations 
(MIC) in liquid media or inhibition zone diameters (IZD) on solid media. 
Regardless of how the data is generated, the laboratory measurements in mg/L 
(for MIC) or mm (for IZD) need to be interpreted in terms of susceptibility versus 
resistance. For this classification, thresholds, also known as breakpoints or cut-
off values, are needed to distinguish between the categories. There are two 
major ways of setting those thresholds, i.e. based on clinical breakpoints or 
using ecological cut-offs (ECOFFS). For clinical breakpoints, in vivo data and 
PK/PD data are used. For ECOFFS, in vitro data are used, with thresholds set by 
international standardisation bodies like the Clinical and Laboratory Standards 
Institute (CLSI) in the USA or the European Committee on Antimicrobial 
Susceptibility Testing (EUCAST) or by the researcher based on normalised 
resistance interpretation (NRI). In this introduction, methods of measurement 
and methods of interpretation will be described, including their strengths and 
weaknesses, as well as the role of standardisation bodies. 
 
3.1.1 Measurement 
3.1.1.1 Minimum Inhibitory Concentrations  
By definition, the MIC is the lowest concentration of an antimicrobial 
which can prevent visible growth of bacteria (Koeth et al., 2004). MICs have 
often been criticized because of the unnatural conditions through which they are 
generated (Turnidge and Paterson, 2007). Moreover, they have been reported 
(Koeth et al., 2004) to lack reproducibility. Repeat results should differ by no 
more or less than a two-fold dilution but often they are less consistent. Factors 
that could contribute to this variability include the method used in generating 
MICs (e.g. broth macro-dilution, broth microdilution, or agar dilution) (Koeth et 
al., 2004) as well as the choice of medium (e.g. Mueller Hinton, Iso-Sensitest, or 
Sensitest medium, lot to lot variation, divalent cation concentrations and effects 
of additives such as blood), inoculum size and concentration, incubation 
conditions (temperature and duration), and precision in the preparation of 
different concentrations of the antibacterial being used (Koeth et al., 2004). 
Thus, MIC are only meaningful when the methods for determining them are 
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standardised. Despite their limitations, MIC measurements are widely used in 
clinical microbiology and in research, using standardisation of methods and 
interpretation criteria to limit variability (see section 3.1.2). 
  
3.1.1.2 Inhibition Zone Diameters  
Inhibition zone diameters provide an estimate of the lowest 
concentration of an antimicrobial, which can prevent visible growth of bacteria 
on solid media with readings taken in millimetres (mm). The most common 
methods is the disc diffusion test where paper discs with known quantity of 
antimicrobials are applied to the surface of a test agar (Kassim et al., 2016). The 
antimicrobial diffuses away from the disc forming a concentration gradient 
which inhibits the growth of bacteria at a certain point and hence causes a zone 
of inhibition (Turnidge and Paterson, 2007). The zone extends until the 
concentration of the drug is insufficient to inhibit the growth of the organism 
(Koeth et al., 2004). An alternative method is the antimicrobial gradient method 
or elipsometer test (E-test), which is based on growth inhibition on solid media 
by a strip that contains a gradient of antimicrobial concentrations rather than 
just a single concentration as in the disc diffusion test (Reller et al., 2009). 
There are several factors that have been reported to influence IZD. The zone of 
inhibition can be affected by the rate at which the drug diffuses through the 
agar and the rate of growth of bacteria (Koeth et al., 2004). The rate of 
diffusion of the antimicrobial through the media depends on the concentration 
of the antimicrobial, molecular weight of the antimicrobial, solubility properties 
of the antimicrobial, pH, ionization, incubation temperature and binding on the 
agar. Aside from the rate of diffusion of the antimicrobial, the choice of agar is 
also believed to influence IZD (Koeth et al., 2004). The depth of agar 
recommended for use is 4 mm ± 0.5 mm (Barry and Fay, 1973). Plates with 
shallow agar may produce false positive results for susceptibility, as the 
antimicrobial compound will diffuse further than it should. The size of the 
inoculum is another factor (Koeth et al., 2004; Turnidge and Paterson, 2007). If 
the size of the inoculum is too small, the zone of inhibition will be larger than it 
is supposed to be and if the inoculum is large, the zone of inhibition will be 
smaller. Some assays may be affected by excessive thymidine or thymine, which 
inhibits the effects of sulphonamide and trimethoprim resulting in smaller zones 
of inhibition or no zones at all. The incorrect concentration of divalent cations 
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(calcium and magnesium) will affect the results of aminoglycoside and 
tetracycline tests against P. aeruginosa. Excess cation concentration will result 
in reduced zone sizes and low concentration will increases zone sizes (Koeth et 
al., 2004). There are media that have been specifically formulated to prevent 
the effect of these factors (e.g. Mueller Hinton agar). The method is well suited 
for water soluble antimicrobials (Turnidge and Paterson, 2007). A limitation of 
the method is that zones of inhibition do not always have clear or regular 
boundaries, making measurement subjective and introducing error. 
 
3.1.2 Interpretation and standardisation 
3.1.2.1 History and activity of standardising bodies 
The CLSI and EUCAST, which was established later, have a common goal 
of developing standards, formulating guidelines to ensure the quality of 
laboratory testing, harmonising interpretation, and improving patient care 
(EUCAST, 2015; Kassim et al., 2016). CLSI was first established in 1968, then 
known as the National Committee for Clinical Laboratory Standards (NCCLS) 
(Barry, 2007). The organisation came into existence because of a discussion that 
was held by 15 organisations that sat with a common goal of finding ways to 
improve what laboratories are doing for patients and subsequently developing a 
consensus process for standardisation. The organisation was accredited by the 
American National Standards Institutes (ANSI) as a voluntary consensus 
standardisation organisation. In 2005, the name NCCLS was changed to CLSI to 
encompass and embrace the international focus of this organisation (Lovgren et 
al., 2007). The CLSI governance structure is comprised of a board of directors in 
which there is a consensus council and an expert panel for each specialty (e.g. 
medics, veterinarians, policy makers, microbiologists, educators and 
pharmacists). Within the consensus council there are document development 
committees, subcommittees and working groups (e.g. Antimicrobial Resistance 
Subcommittees). EUCAST was formed in 1997 (Kahlmeter et al., 2015). The 
current EUCAST structure incorporates different professional bodies from 
Europe, e.g. the pharmaceutical industry, veterinarians, medics, microbiologists 
and media manufacturers. Subcommittees within EUCAST (e.g. the EUCAST 
Veterinary Subcommittee Testing (VetCAST) were formed to cover various 
aspects of susceptibility testing, including terminology, breakpoint setting and 
methodology, and to develop guidelines (Kahlmeter et al., 2015). The Steering 
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Committee makes the final decision and the rest of the consultation is done by 
the General Committee. 
 
While these two organizations seem to have the same mission, they differ 
as far as operation, decision making, delivery of outputs and structure are 
concerned. For example, in contrast to EUCAST the pharmaceutical industry has 
an upper hand in decision making in CLSI (Kassim et al., 2016). The Food and 
Drug Administration (FDA) makes decisions on clinical breakpoints before they 
are adopted by CLSI and this raises significant concerns on the likelihood of bias 
which favours the interests of the FDA (Kassim et al, 2016). In EUCAST, the 
industry has no formal position and there is no seat for industry on either the 
Steering Committee or the General Committee, although there is a working 
relationship between the industry and EUCAST. The industry is frequently 
consulted on technical issues and vice versa (Kassim et al., 2016). Moreover, 
open public consultations are an integrated part of the EUCAST decision-making 
process. When it comes to financial support, CLSI relies greatly on income from 
sales of documents, membership dues and the industry while the industry is not 
allowed to contribute financially to any of the activities offered by EUCAST 
(Kassim et al., 2016). EUCAST is financed by the European Society of Clinical 
Microbiology and Infectious Diseases (ESCMID) and to some degree by the 
European Centre for Disease Prevention and Control (ECDC) (Kassim at al., 
2016). This is done to prevent commercial interests overruling critical 
considerations (e.g. health-related) in decision making. Due to such financial 
reasons, CLSI guidelines are only accessible annually through subscription at a 
cost of US $350 for members and a cost of US $500 for non-members, which may 
be a problem for microbiology laboratories in resource-poor settings (Kassim et 
al., 2016). On the other hand, EUCAST guidelines and other information (e.g. 
MIC distributions, clinical breakpoints, ECOFFS and rationale documents) are 
openly accessible online. Finally, CLSI may only include breakpoints for 
antimicrobials that are registered in the US (Kassim et al., 2016). This is in 
contrast to EUCAST, which has made an effort to include clinical strains from 
countries with epidemiology that differs widely from Europe and also for new 
antimicrobials (Kassim et al., 2016). Many countries are now shifting from the 
utilization of CLSI to EUCAST guidelines. For example, at the ESCMID conference 
in Amsterdam (April 2019), representatives from Brazil and China presented on 
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adoption of EUCAST guidelines by their countries (RN Zadoks, personal 
communication). However, in the future, collaboration between the two 
organizations will be needed for truly harmonizing breakpoints. 
 
3.1.2.2 Clinical breakpoints 
Clinical breakpoints refer to those concentrations that separate strains 
where there is a high likelihood of treatment success from those bacteria where 
treatment is bound to fail (Turnidge and Paterson, 2007). These breakpoints are 
derived from prospective human clinical studies comparing outcomes with the 
MICs of the infecting pathogen. Clinical breakpoints can also be calculated from 
knowledge of pharmacodynamic (PD) parameters and the dimension of that 
parameter that predicts efficacy in vivo (Turnidge and Paterson, 2007). Some 
scientists refer to them as pharmacokinetic/pharmacodynamic (PK/PD) 
breakpoints, where data that have been generated in animal models are 
extrapolated to humans by using mathematical or statistical techniques 
(Kahlmeter et al., 2015; Turnidge and Paterson, 2007). 
 
3.1.2.3 Ecological cut-offs 
Ecological cut-offs are threshold concentrations (also called 
microbiological breakpoints) that distinguish wild type (WT) populations of 
bacteria from those with acquired or selected resistance mechanisms (Kronvall 
et al., 2011), with the same rationale applying to IZD data. Data used in 
deducing this type of threshold are generated from moderate to large numbers 
(at least 50 observations) of MIC or IZD tests, sufficient to describe the WT 
population (Kahlmeter etal., 2015). In this context, a WT isolate is defined as an 
isolate that does not harbour any acquired or selected resistance to the 
particular antibacterial being examined or to antimicrobials with the same 
mechanism/site of action (Turnidge and Paterson, 2007). To reduce confusion 
about the meaning of the term breakpoint, EUCAST proposed the use of the term 
'epidemiological (or WT) cut-off value' to replace the term 'microbiological 
breakpoint' (Turnidge and Paterson, 2007). Epidemiological cut-off values were 
created to describe biological phenomena of phenotypic resistance rather than 
simply detecting or classifying the presence or absence of resistance or 
resistance genes or predicting clinical outcomes. They are useful when there is 
no consensus on clinical breakpoints or when resistance has not yet been 
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described (Kahlmeter et al., 2015). However, EUCAST has not provided a clear 
method as to how their thresholds are established (Kronvall, 2011). 
 
3.1.2.4 Normalised Resistance Interpretation 
Normalised Resistance Interpretation (NRI) can be used to estimate 
ECOFFS (Kronvall et al., 2011). The NRI method works under the assumption 
that, for as long as the WT on the sensitive side is not affected by resistance 
development, a normalised peak can be reconstructed for MIC or IZD 
distributions. This method has been widely used in defining the WT population in 
IZD histograms and for calculating ECOFFS (Kronvall et al., 2011; Ruane et al., 
2007; Smith and Christofilogiannis, 2007). It eliminates the need to estimate cut-
off values by inspection from distributions provided by EUCAST, although it can 
be applied to EUCAST data to provide an objective estimate of the cut-off value. 
Through the use of the NRI method, it was discovered that estimated EUCAST 
ECOFFS for some species-drug combinations were not accurate as they did not 
include all WT isolates (Kronvall et al., 2011). The conclusion was that EUCAST 
had adjusted ECOFF values and underestimated the proportion of WT isolates in 
some of the reference populations (Kronvall et al., 2011). Moreover, for some 
pathogens (e.g. S. aureus) they found bimodal distributions which indicated that 
the EUCAST distributions could contain non-WT isolates with some kind of AMR 
mechanisms (Kronvall et al., 2011). The NRI method can be applied for 
calculation of EUCAST thresholds, whereby the organisation would need to give 
formal endorsement of proposed thresholds before they could be considered 
official EUCAST thresholds, as well as for the calculation of cut-off values for 
other datasets and by other organisations and individuals. To differentiate 
between EUCAST-approved and unofficial cut-offs, the terms ECOFF and cut-off 
for WT (COWT) will be used, respectively.   
 
3.1.3 Aim of this chapter 
This chapter will focus on calculating COWT values for E. coli from poultry 
in Tanzania from samples described in Chapter 2 and on determining the 
prevalence of AMR using different criteria for interpretation, i.e. clinical 
breakpoints, ECOFF and COWT. The aim is to determine whether the prevalence 
of AMR will vary depending on interpretation criteria.  
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3.2 Materials and Methods 
3.2.1 Phenotypic identification of E. coli colonies using Chromogenic Agar 
3.2.1.1 Preparation of Chromogenic agar medium 
Chromogenic agar (CHROMagarTM ECC, Sigma Aldrich, UK) was prepared by 
mixing 32.8 grams of CHROMagar powder in one litre of sterile distilled water 
and heating to boiling temperature. Agar was then poured into each plate and 
allowed to dry overnight before use. 
 
3.2.1.2 Phenotypic Identification using Chromogenic agar (CHROMagar) 
CHROMagar (Sigma Aldrich) was used for simultaneous identification and 
differentiation of Escherichia coli from other bacteria. The media contains 
chromogenic substrates (Salmon-GAL) which upon interaction with β-
glucuronidase in E. coli isolates cleave and release a chromophore that makes E. 
coli colonies appear blue. Coliforms that lack this enzyme (Enterobacter, 
Klebsiella and Citrobacter) are expected to be mauve, while non-coliforms 
appear white or are completely inhibited from growing. Per poultry farm, a 
single isolate was used, obtained from plate sweeps that were grown on 
MacConkey agar as described in section 2.2.8. Prior to inoculation on 
CHROMagar, individual isolates (a single isolate per plate) with characteristic 
pink-dry appearance were picked from MacConkey plates and inoculated in 
Luria-Bertani broth (Oxoid, Canada), followed by incubation overnight at 37 ºC. 
Then, 50 µl of the pure culture was inoculated on CHROMagar, spread evenly 
using a sterile L-shaped spreader (VWR, UK, catalogue number 6121560P) and 
incubated overnight at 37 ºC. Afterwards, phenotypically blue colonies (i.e. pure 
colonies) were picked from each individual CHROMagar plate (one per plate) and 
subjected to further species confirmation using quantitative uidA PCR.  
 
3.2.1.3 Reference strains  
Reference strains were obtained from the Veterinary Diagnostic Services 
laboratory at the University of Glasgow. Isolates originated from samples taken 
from dogs. The identity of isolates was determined using the API 20E strips (API 
system by Biomerieux-https://www.biomerieux.co.uk/product/apir-id-strip-
range). Escherichia coli was used as a positive control and Klebsiella as a 
negative control for both phenotypic and genotypic confirmation of E. coli 
Isolates. Both reference isolates were confirmed to be resistant to all 
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antimicrobials used in this study by the Veterinary Diagnostic Services 
laboratory. 
 
3.2.2 Molecular detection of E. coli using quantitative uidA PCR 
3.2.2.1 DNA extraction 
DNA extraction was conducted using a QIAamp DNA mini Kit (Qiagen, UK) 
as described by Khan and Yadav (2004) with an optimised standard operating 
procedure. The procedure involved taking a single isolate from each CHROMagar 
plate described in section 3.2.1.2 and resuspending the isolate in 1 ml of Luria-
Bertani media (VWR, UK). Then, 50 µl of the suspension was taken and added 
into a 1.5 ml microcentrifuge tube and centrifuged at 5000 x g (7500 revolutions 
per minute (rpm) (Horizon Model 642E, Fisher Health Care, Fair Lawn) for 10 
minutes. The remaining portion of the culture suspension was incubated at 37 ºC 
overnight and used for susceptibility testing in the next steps as explained in 
section 3.2.4. Meanwhile, the supernatant of the centrifuged aliquot was 
discarded and the bacterial pellet resuspended in 180 µl buffer ATL. To remove 
any contaminating proteins, a broad-spectrum serine protease (proteinase K) 
was added to the pellet and the mixture was incubated at 56 ºC for 1 hour. A 
protein precipitating solution, buffer AL (200 µl), was added, then pulse-
vortexed for 15 seconds and incubated at 70 ºC for 10 minutes. Ethanol (200 µl) 
was added and the mixture transferred to a QIAamp Mini spin column and 
centrifuged at 6000 x g (8000 rpm in Horizon Model 642E)) for 1 minute. This was 
followed by two wash steps: the addition of buffer AW1 and centrifugation at 
6000 x g for 1 min; and then addition of W2 and centrifugation at 20,000 x g 
(14,000 rpm in Horizon Model 642E) for 3 minutes. The filtrate was discarded in 
each step. Buffer AE (200 µl) was used for final elution followed by incubation 
for 1 minute and centrifugation at 6000 x g (8000 rpm) in Horizon Model 642E for 
1 minute. The extracted DNA concentration was measured with a Nanodrop 
(Nanodrop-2000 Spectrophotometer, NanoDrop Technologies).  
 
3.2.2.2 Quantitative uidA PCR 
Confirmation of E. coli species identity was performed via real-time 
quantitative polymerase chain reaction (qPCR), which targets the uidA gene in E. 
coli, a common gene found in almost all E. coli with a coding region of about 
1809 base pairs (Jefferson et al., 1986). DNA from reference isolates of E. coli 
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and Klebsiella was used for positive and negative controls, respectively. All qPCR 
assays were performed using the Rotor gene system (Applied Biosystems, Foster 
City, CA, USA). The uidA qPCR primers and probe used for detection were as 
described in Frahm and Obst (2003). The forward primer was 5'-GTG TGA TAT 
CTA CCC GCT TCG C-3', the reverse primer was 5'-AGA ACG GTT TGT GGT TAA 
TCAGGA-3’ and the probe FAM – TCG GCA TCC GGT CAG TGG CAG T – BHQ1. The 
probe was labelled with 56-FAM as a reporter fluorescent dye at the 5' end and 
the 3’ end with BHQ_1 as the quencher dye. Reactions for uidA qPCR were 
performed as described in Frahm and Obst (2003). Briefly, qPCR reactions were 
performed in a 15 µL reaction volume using 2 × Quantitect Probe PCR master mix 
(Qiagen, Valencia, CA, USA), 0.4 µM of each primer, 0.2 µM of probe (Intergrated 
DNA Technology, Belgium), and 5 µl of template DNA from presumptive E. coli 
isolates. PCR conditions were 95 ºC for 2 minutes, 95 ºC for 5 minutes, followed 
by 45 cycles of 95 ºC for 5 seconds and 60 ºC for 5 seconds. Results were 
analysed using Rotor gene software.   
 
3.2.3 Preparation of Mueller Hinton agar 
The Mueller Hinton agar was prepared by suspending 38 g of medium in 
one litre of distilled water. The mixture was then autoclaved at 121 ºC for 15 
mins, allowed to cool at room temperature to 60 ºC and poured into plates in a 
biosafety cabinet to avoid contamination. After the media solidified, the plates 
were placed in an incubator at 37 ºC overnight to check whether there would be 
any growth on the plates which would indicate contamination in media 
potentially arising from unsterile conditions while pouring the media in plates or 
that the media was insufficiently autoclaved. Upon confirmation that there was 
no contamination, the plates were temporarily stored in the refrigerator before 
use.  
 
3.2.4 Culture and susceptibility testing using disc diffusion test 
AST was conducted using standardised disc diffusion testing (Bauer et al., 
1966). Antimicrobial susceptibility of E. coli was tested against four (4) 
antimicrobials at standard disc quantity based on EUCAST recommendations, i.e. 
ceftazidime (30 µg), ciprofloxacin (5 µl), imipenem (10 µg) and tetracycline (30 
µg).The procedure involved taking the remaining aliquot of a culture suspension 
from section 3.2.2.1 above, which contained a single isolate that was verified 
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through uidA PCR to be E. coli in section 3.2.2.2 and testing it for susceptibility. 
The culture suspension was diluted with distilled water to a density that was 
equivalent to 0.5 MacFarland. Large plates (90 mm in diameter) were used with 
Mueller Hinton agar (4 to 6 mm in depth). Plates were air-dried for about 30 
minutes before inoculation. Bacterial suspensions at 0.5 MacFarland were 
streaked evenly onto the surface of the medium with a plate spreader (VWR, UK, 
catalogue number 6121560P). After the inoculum dried for 3 to 5 mins, the four 
antimicrobial disks were placed on agar with flamed forceps and gently pressed 
down to ensure contact. Plates were then incubated at 37 ºC under aerobic 
conditions. After overnight incubation, the zone diameters were measured with 
a vernier caliper on the under surface of the petri dish near the agar surface.  
 
3.2.5 Data analysis 
For each antimicrobial tested, inhibition zone diameters were analysed to 
determine the prevalence of susceptible and resistant isolates using clinical 
breakpoints, ECOFFS or COWT values based on NRI. Clinical break points were 
derived from CLSI guidelines (CLSI 2016). ECOFFs were taken from EUCAST 
guidelines (EUCAST, 2017). Estimates for the EUCAST ECOFF for 30 µg 
tetracycline were not found on the EUCAST website hence an alternative which 
is a tetracycline analogue (i.e. tigecycline) with the desired concentration was 
used instead. All calculations of the COWT were conducted according to 
specifications in a published protocol by Kronvall and Smith (2016) using a 
spreadsheet made available by the authors (European patent No 1383913, US 
Patent No. 7,465,559; https://doi.org/10.1111/apm.12624).This spreadsheet 
was used to generate histograms of IZD and to calculate COWT values for each 
compound. The prevalence of resistance among poultry E. coli isolates from 
Tanzania was calculated based on each of the three thresholds, i.e. clinical 
breakpoints, ECOFFS and COWT. 
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3.3 Results 
3.3.1 Phenotypic and molecular detection of E. coli 
Of the 74 plate sweeps that were harvested from plain MacConkey agar in 
Tanzania, frozen and shipped to the UK and re-cultured, 69 samples showed 
growth while 5 samples did not (Table 3.1) demonstrating loss to follow up (7%) 
after storage and handling.  
 
Table 3.1 Number of plate sweeps by farm type showing growth on MacConkey plates after re-
culture in Glasgow of frozen material shipped from Tanzania. 
 
69 presumptive E. coli isolates taken from MacConkey and subcultured on 
CHROMagar, all showed growth. Not all presumptive E. coli colonies from 
MacConkey agar (i.e. pink dry colonies) were blue on CHROMagar, which is 
supposed to be sensitive and specific for E. coli (Figure 3.1). Based on 
subsequent confirmation with uidA qPCR, 11 isolates that were white, mauve or 
blue-and-white were confirmed to be E. coli and six isolates that appeared blue 
on CHROMagar were confirmed not to be E. coli (Table 3.2). 
 
Table 3.2 Confirmation of E. coli species via uidA PCR for individual isolates from plate sweeps 
grown on CHROMagar 
 
 
 
Farm type Sample Growth No Growth 
Extensive 20 20 0 
Semi intensive  17 15 2 
Intensive  18 17 1 
Broiler  19 17 2 
Total  74 69 5 
Colour on CHROMagar Total Positive Negative 
Blue 49 43 6 
Mauve 6 2 4 
White 6 4 2 
White and blue 8 5 3 
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Figure 3.1 Phenotypes observed on CHROMagar. Each phenotype was found among E. coli and 
non-E. coli isolates based on uidA-based genotypic species confirmation 
 
 
Figure 3.2 E. coli (uidA gene) standard curves obtained after amplification of reference strain 
DNA from serial dilution of A: 1.0E+01; B:1.0E+02; C:1.0E+03; D:1.0E+04; E: 1.0E+05; F: 1.0E+06; 
G: Negative control - Klebsiella spp. DNA  
 
 
3.3.2 Susceptibility testing 
  The range of IZD values differed between antimicrobials (Figure 3.3). At 
least one isolate per antimicrobial was observed to have a zone diameter of 6 
mm (Table 3.3). Except for tetracycline, the wild type cut-off (COWT) was lower 
than clinical breakpoints (CB) and ecological cut-offs (ECOFF).  
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Figure 3.3 Growth of Escherichia coli on Mueller Hinton agar with inhibition zones seen around 
ceftazidime (CAZ), ciprofloxacin (CIP), imipenem (IPM) and tetracycline (TE). The red arrow 
demonstrates how readings of the inhibition zone diameters (IZD) were taken. 
 
Analysis of the IZD distributions using the NRI method was used to 
estimate the mean zone size and standard deviation (SD) for WT isolates based 
on normalised histograms (Figure 3.4) and to estimate COWT for each compound 
(Table 3.3). 
 
Table 3.3 Observed range of inhibition zone diameters and output from Normalised Resistance 
Interpretation, including the functional peak, standard deviation (SD) of the functional peak, and 
cut-off values for wild type (COWT). 
Antimicrobial  Range (mm) Functional 
peak (mm) 
SD (mm) COWT (mm) 
Ceftazidime  6 – 38 29 4.8 15 
Ciprofloxacin 6 – 40 26.5 5.1 14 
Imipenem 6 – 38 24.5 4.7 13 
Tetracycline  6 – 21 18 2.1 14 
 
  Except for tetracycline, the calculated SD values for IZDs of ciprofloxacin, 
imipenem and ceftazidime were larger than the recommended 4mm limit (Smith 
et al., 2012). According to Smith and colleagues, higher SD values maybe a result 
of fewer number of  WT strains in a distribution or lack of homogeneity which 
may manifest in situations where significant numbers of Non-WT strains with low 
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level resistance are present in a strain set (Smith et al., 2012), hence affecting 
the derivation of an accurate COWT. As a result, it is recommended that COWT 
produced from data that generates normalised distribution of putative WT 
strains with SD > 4mm should be rejected or treated with caution (Smith et al., 
2012). 
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Figure 3.4 Histograms of the distribution of inhibition zones produced by discs containing 30µg of ceftazidime, 5µg of ciprofloxacin, 10 µg of imipenem or 30µg of 
tetracycline. The continuous black curved line represents the 4-point rolling mean, the dashed line is the wild type cut-off (COWT) calculated from the data using 
the Normalized Resistance Interpretation method. Graphs were prepared in Microsoft Excel, using the spreadsheet made available by P. Smith, W. Finnegan, and G. 
Kronvall (European patent No 1383913, US Patent No. 7,465,559). 
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3.3.3 Comparison of EUCAST reference data and Tanzanian poultry data 
Comparisons of the distribution of IZDs for each antimicrobial compound based 
on EUCAST data and data generated in this study are shown in the histograms in 
Figure 3.5 below, together with CB, ECOFF and COWT-based threshold values for 
interpretation.  
 
 
Figure 3.5 Distribution of inhibition zone diameters produced by 30 µg ceftazidime, 5 µg 
ciprofloxacin, 10 µg imipenem, or 30 µg tetracycline discs against Escherichia coli. The coloured 
bars indicate results for E. coli from poultry cloacal swabs from Tanzania (n = 59). Black bars 
indicate the distribution of IZDs from E. coli isolates from EUCAST data (n = 11,875, 36,774, 
4,600 and 326 for ceftazidime (CEFT), ciprofloxacin (CIPRO), imipenem (IMI) and tetracycline 
(TET), respectively). Dashed lines represent CLSI clinical breakpoints (blue), EUCAST ecological 
cut-off values (red; not available for TET) and cut-off wild type values (black) based on 
normalised resistance interpretation of the data from Tanzanian poultry. 
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All four distributions revealed a shift to the left for IZD values of E. coli from 
Tanzanian poultry when compared to the EUCAST reference data, indicating 
lower levels of susceptibility. The EUCAST distribution for tigecycline (an 
analogue for tetracycline) was used since the distribution for tetracycline with 
the desired concentration (30 µg) was not available in the EUCAST website. It is 
only for tetracycline that the CB was smaller than COWT. For all compounds, CB 
differed from COWT by 5 mm or less whilst ECOFFS were much higher than COWT 
values. 
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3.3.4 Prevalence of AMR in Escherichia coli from Tanzanian poultry 
Prevalence of AMR was calculated based on three thresholds for resistance (Table 3.4). Clinical breakpoints were acquired from 2016 
CLSI guideline and EUCAST ECOFF from the EUCAST website. The CLISI guideline used was Performance Standards for Antimicrobial 
Susceptibility Testing. 26th edition, CLSI supplement M100S, ISBN 1-56238- 924-6 [Electronic]). Estimates of the EUCAST ECOFFS for TET 
30 µg distribution were not available on the EUCAST website hence tigecycline data was used. 
 
Table 3.4 Proportion of resistant (R), non-wildtype (non-WT),susceptible (S) or wild type (WT) Escherichia coli isolates from poultry cloacal swabs from Tanzania 
based on clinical breakpoints (CB), EUCAST ecological cut-off (ECOFF) and wild-type cut-off (COWT) as calculated using normalised resistance interpretation of the 
data generated in the current study. 
 
With the exception of ciprofloxacin, estimates for the prevalence of resistance or non-WT were similar for CB and COWT-based 
interpretation. By contrast, prevalence of non-WT was much higher based on EUCAST ECOFF-based interpretation. 
 
 
 
Antimicrobial CB S (%) R (%) ECOFF 
(mm) 
WT (%) R (%) COWT (mm) WT (%) Non-WT (%) 
Ceftazidime 17 98.3 1.7 24 54.2 45.8 15 98.3 1.7 
Ciprofloxacin 19 67.8  32.2 25 35.6 64.4 14 81.4 18.6 
Imipenem 15 96.6  3.4 24 64.4 35.6 13 96.0 4.0 
Tetracycline  11 32.2  67.8 - - - 14 30.5 69.5 
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3.4 Discussion 
In this study, prevalence of AMR in E. coli was estimated using two 
standard criteria, i.e. CB and ECOFF, and bespoke COWT values calculated from 
the data. Based on CB and COWT, prevalence of AMR was low for ceftazidime and 
imipenem (< 4%), intermediate for ciprofloxacin, and high for tetracycline (> 
67%). High prevalence of tetracycline resistant isolates in the current study 
matches findings in previous studies conducted in the northern zone of Tanzania 
(Caudell et al., 2017; Hamisi et al., 2014; Rugumisa et al., 2016). Prevalence of 
ciprofloxacin resistance ranged from 18.6% to 64.4% in the current study 
depending on the criteria used. In previous studies in the northern zone of 
Tanzania, Hamisi et al. (2014) also reported high ciprofloxacin resistance (54.5%) 
in poultry whereas relatively limited resistance to ciprofloxacin (3.5%) was 
reported by Rugumisa et al. (2016). As in the current study, Hamisi et al. (2014) 
used the Kirby-Bauer method to analyse susceptibility of the isolates and clinical 
breakpoints for interpretation yet they found different estimates suggesting true 
differences in the AMR prevalence in the study populations. By contrast, 
Rugumisa et al. (2016) used the breakpoint plate method (as used in Chapter 2) 
and clinical breakpoints to determine the resistance of E. coli isolates so that 
differences in prevalence estimates between their study and the current study 
may partly be due to differences in methodology. Imipenem and ceftazidime 
were seldom used in poultry production according to qualitative survey data on 
antimicrobial use in Arusha (Sindiyo et al., 2018) and Moshi (see Chapter 4). 
Therefore, it was not anticipated that there would be resistance against these 
antimicrobials. Nonetheless, studies that were conducted within the same 
districts in the past revealed the existence of isolates that were resistant to 3rd 
generation cephalosporins in poultry. For instance, in a study by Hamisi et al. 
(2014), 29.8% of poultry isolates were observed to be resistant to cefotaxime (a 
3rd generation cephalosporin) whilst Rugumisa et al. (2016) found relatively 
lower prevalence of ceftazidime resistance estimated at 6.5%. In the present 
study, resistance to ceftazidime was lower but it was detected. Though this 
observation may not be linked with direct use of these antimicrobials at farm 
level, it suggests that alternative sources could be present which introduce 
resistant bacteria in poultry farms. A study by Lyimo et al., (2016) in the 
northern zone in Tanzania, discovered bacteria harbouring blaTEM genes 
(encoding broad spectrum β-lactamase which hydrolyses many β-lactams) and 
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blaCTX-M79 (encoding enzymes which exert hydrolytic activity against ceftazidime) 
were present in closed (i.e. tap water) and open water sources (i.e. lakes or 
rivers).  Since the majority of farmers in the northern zone use tap water in 
poultry production (Sindiyo et al., 2018), presence of blaTEM genes and blaCTX-M79 
in tap water may provide a potential explanation for ceftazidime resistance in E. 
coli isolates from animals that are not treated with those compounds. Prior to 
this study, no known study in Tanzania investigated imipenem resistance in 
poultry and therefore there is no direct evidence that could help understand the 
source of imipenem resistance in poultry. The use of imipenem in poultry 
production in Tanzania is not allowed officially, however, it may happen 
informally. Moreover, use in humans may result in imipenem resistant E. coli 
that can be acquired by poultry via human waste (e.g. faeces).  
  
In contrast to AMR prevalence estimates based on CB values, prevalence 
estimates based on ECOFFS were very different from those based on COWT. The 
proportion of non-WT isolates was more than 35% for a carbapenem (imipenem), 
a 3rd generation cephalosporin (ceftazidime) and a fluoroquinolone 
(ciprofloxacin). All three categories are listed on the WHO’s Critically Important 
Antimicrobials list, with the latter two included among the Highest Priority 
Critically Important Antimicrobials (HP-CIA) (WHO, 2017). Such a high prevalence 
of non-susceptibility in E. coli to HP-CIA could be of major public health 
concern. This shows that estimates of AMR prevalence and hence (apparent) 
public health concerns can be highly dependent on the choice of threshold. 
Similar dependence of AMR prevalence estimates on the choice of threshold has 
been reported in other studies with animal derived data, e.g. for E. coli from 
wild ungulates (Dias et al., 2015). On the one hand, this shows the importance of 
the NRI method as an objective method to generate cut-offs from specific 
datasets being examined including those of non-human or non-clinical origin. On 
the other hand, if (low level) resistance is highly prevalent in such specific 
datasets, use of the NRI method may fail to recognize it because it could fall 
within the normal distribution. One of the major limitations of the NRI-method is 
that cut-offs produced from small datasets may not be accurate or 
representative of a wider population. For instance, for three antimicrobials in 
our data, calculated SD values exceeded the recommended limit (Smith and 
Christofilogiannis, 2007). Indeed, for this reason, results from the current study 
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should be interpreted with caution. In addition, some of the distributions in the 
current dataset appeared bimodal rather than unimodal. The NRI method works 
from high IZD values to low IZD values and uses the highest peak in the data to 
estimate COWT values, limiting the impact of the second peak at lower IZD on the 
estimates. Still, the existence of a second peak, which could potentially indicate 
an intermediate population, violates the assumption of normal distribution of 
the data (Kronvall et al., 2011) and suggests that a larger dataset or further 
investigation of this phenomenon may be needed.  
 
A third key feature of the results from this study is that the distribution of 
IZD of E. coli isolates was shifted to the left in comparison to the EUCAST 
reference data. This meant that poultry E. coli isolates had narrower zones and 
were less susceptible, even if they were still classified as susceptible or WT 
based on thresholds for categorical interpretation. Similar shifts have been 
observed in gram-negative isolates from wildlife compared to EUCAST data (Dias 
et al., 2015). This shift could be explained by various factors, including inherent 
differences between humans and animals. The gastrointestinal (GI) tract of 
animals, particularly ruminants and other herbivores, is different from the 
human GI tract, and more complex. It is possible, in theory, that this results in 
upregulation of generic efflux mechanism for toxins and antimicrobials. This 
mechanism has been suggested to explain a similar shift observed for gram-
positive pathogens (S. aureus) on organic farms compared to conventional farms, 
where the IZD were smaller for isolates from conventional farms (Tikofsky et al., 
2003). It is possible that exposure to antimicrobials from feed or water may have 
led to upregulation of generic detoxification mechanisms and efflux pumps in E. 
coli from poultry in Tanzania, leading to the observed shift in IZD distribution. 
Finally, considering that the poultry data and EUCAST data were generated in 
different laboratories, variation could be due to differences in methodology 
despite all attempts at standardisation (Smith and Christofilogiannis, 2007). 
Although the exact reason or the relative contribution of different reasons to the 
observed phenomenon is unknown, a comparison of wild-type distributions for E. 
coli from humans and birds may shed some light on the question (Sjölund et al., 
2009). In Sjolund’s study, data were generated in a single laboratory so there 
were no differences in methodology. Avian isolates in this study originated from 
wild birds. The wild-type distribution for the bird isolates did not differ from the 
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wild-type distribution for humans, suggesting that birds and humans do not have 
inherently different E. coli isolates. The birds in that study were all wild birds 
from the Arctic (Sjölund et al., 2009). Therefore, they would not have been 
exposed to antimicrobial treatment. Sjolund’s data suggest that the resistance 
profiles of E. coli from birds is not inherently different from E. coli from humans 
and implies that antimicrobial use may be important in explaining the shift to 
the left for E. coli from poultry in Tanzania. There are many assumptions and 
uncertainties in this argument, but antimicrobial use is widespread on Tanzanian 
poultry farms. This will be discussed in Chapter 4, together with 
recommendations for future work.  
 
The misclassification of coliform isolates from health poultry by 
CHROMagar may be linked to occurrence of different phylogroups of E. coli in 
humans and poultry (Logue et al., 2017). Variable growth and colony colouration 
of different E. coli strains on selective agar has been described before (Kase et 
al., 2015). Thus, commercially available bacterial indicator media give false 
positive or false negative results and should be described with caution in 
agricultural applications, as previously described for methicillin resistant S. 
aureus in bulk tank milk (Virgin et al., 2009). Although assessment of culture 
methods was not the aim of this chapter, the results show that methodology and 
results of both bacteriological culture and AST developed primarily for human 
use need to be interpreted with caution when applied in other settings. 
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CHAPTER FOUR 
 
GENERAL DISCUSSION AND RECOMMENDATION 
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4.1 General Discussion 
In the present study it was shown that healthy poultry are a reservoir of 
AMR bacteria in the Northern Zone of Tanzania (Chapter 2), indicated by 
presence of resistant E. coli in chicken cloacal swabs. This finding was expected 
as there is quite widespread use of antimicrobials in poultry farming in Arusha 
(Sindiyo et al., 2018), including evidence seen while collecting samples in 
extensive farms where inputs into poultry production are minimal but 
antimicrobial use was observed. A similar survey of poultry management and 
antimicrobial use practices was conducted in Moshi during collection of the 
cloacal swabs that are described in Chapter 2. However, only qualitative data on 
antimicrobial use was collected in the present study, presented in Figure 4.1 and 
Table 4.1. Verbal consent was obtained from each poultry farmer before the 
interview was conducted in front of a witness. Questions regarding antimicrobial 
use were open ended whilst questions on how antimicrobials were administered 
were closed questions (i.e. whether poultry keepers administered through feed 
or water). This survey revealed that the majority of poultry farmers 
administered antimicrobials through water whilst none of the poultry keepers 
added antimicrobials in feed (Table 4.1). Addition of antimicrobials in drinking 
water, together with the presence of AMR E. coli in water (see Chapter 3), 
would seem to provide the ideal situation for selection of resistant E. coli in the 
gastro-intestinal tract of poultry. 
 
Table 4.1 Number of poultry farmers per farm type administering antimicrobials in water or feed 
in Moshi Urban District, Northern Zone, Tanzania 
 
Poultry is one of the fastest growing sources of animal protein in 
Tanzania. Recent estimates suggest that poultry meat contributes to almost 25% 
Farm type  Adds antimicrobials in 
water 
 
Adds antimicrobials in 
feed 
 Yes No Yes No 
Extensive  7 3 0 10 
Semi-intensive  10 0 0 10 
Intensive  9 1 0 10 
Broiler  8 2 0 10 
Total 34 6 0 40 
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of the meat demand in Tanzania (Wilson, 2015). Therefore, finding resistance in 
poultry isolates raises critical concerns on the food safety since resistant micro-
organisms can find their way into the food chain through meat contamination 
during slaughter and subsequently get consumed if poultry meat is not properly 
prepared. Moreover, poultry have the capacity of shedding resistant 
microorganisms into the environment ultimately transferring them to other 
animals and areas. The use of poultry manure is quite common amongst 
livestock-crop farming communities in the Northern Zone of Tanzania, and 
resistant E. coli from chickens could potentially end up contaminating fruits and 
vegetables. Presence of AMR E. coli on vegetables has been demonstrated in 
South Africa and Europe and was primarily attributed to different water sources 
(Jongman et al., 2016; Araújo et al., 2017) but the use of poultry manure may 
also contribute to the problem. 
 
Tetracycline resistance was common, based on testing of samples on 
break point media (Chapter 2) and based on testing of individual samples with 
formal AST methods (Chapter 3). This was not unexpected because tetracycline 
resistance is common in human and animal isolates in Tanzania and globally 
(Chapter 3). Tetracycline is the most commonly used antimicrobial in poultry 
farms in Moshi (Figure 4.1) and the only compound reported to be used on all 
farm types, which may explain the high level of tetracycline resistance. 
 
 
Figure 4.1 Antimicrobials used in different poultry farm types in Moshi Urban District in the 
Northern Zone of Tanzania based on qualitative surveys on the farms participating in this study. 
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Use of trimethoprim and sulfadiazine was relatively common too and 
reported on four farm types. Tetracycline is cheaper than ciprofloxacin, which 
may explain why it is used widely. Worryingly, however, three of ten 
participating broiler farmers reported use of ciprofloxacin, which is a quinolone 
and belongs to the HP-CIA. Such compounds should not be used in animal 
production. This practice may explain the relatively high prevalence of 
ciprofloxacin resistant E. coli in this region and is of major concern. Equally 
important, Chapter 3 shows that resistance also occurred against other 
compounds (i.e. imipenem and ceftazidime), even though farmers reported no 
use of those compounds (Figure 4.1). Carbapenems are known to have broad 
spectrum activity against gram-positive and gram-negative bacteria. They are 
also considered as the last resort for gram-negative bacteria (Köck et al., 2018). 
Thus, the emergence and spread of resistance to these antimicrobials constitute 
major public health concern. Based on the interviews we did with poultry 
keepers carbapenems were not used in poultry production. Therefore, this study 
highlights the necessity of exploring other sources through which AMR bacteria 
and their determinants could be introduced at farm level in the absence of use 
of antimicrobials. This is pertinent as AMR is a multifaceted problem. There are 
various factors that could contribute to the development and emergence of 
antimicrobial resistant bacteria. In extensive poultry farms, both traditional 
medicinal plants and other antimicrobials were used, both in Arusha (Sindiyo et 
al., 2018) and in Moshi. Frequently used medicinal plants were Msesere, 
Muarubaini and Aloe vera. Whether medicinal plants contribute to AMR or might 
be useful as alternatives to antimicrobials would need further study (Abdallah, 
2011). 
 
In contrast to numerous studies (Van Boeckel et al., 2015; Rugumisa et 
al., 2016; Gerber et al., 2008; Luangtongkum et al., 2006) findings from Chapter 
2 did not support the view that intensification of poultry production is a risk for 
increased resistance. This was somewhat unexpected because utilisation of 
antimicrobials amongst poultry keepers was found to be associated with socio-
economic status of the farmers (Sindiyo et al., 2018; Caudell et al., 2017) and 
the higher ciprofloxacin use among broiler farmers (Figure 4.1) suggests that this 
may also be the case in Moshi. Therefore, higher wealth could be expected to be 
associated with intensive farming practices, higher use of antimicrobials and 
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higher prevalence of AMR. The lack of an association between farm type and 
AMR prevalence suggests that a multifactorial approach may be needed to 
understand the dynamics of AMR prevalence in these poultry systems, including 
detailed analysis of potential sources of selection pressure, including the use of 
medicated feed, treatments, herbal remedies, water and socio-economic 
aspects. Based on conversations with the poultry farmers from Moshi and Arusha 
in this study, the majority of farmers did not seek professional help but rather 
sought advice from other sources, e.g. neighbours or friends (Sindiyo et al., 
2018; personal observation). This may have affected the association between 
farm type and antimicrobial use practices because the source of advice may 
have been similar for all farm types.  It is also a possibility that our findings 
were impacted by other factors, such as those associated with cultural-
ecological practices, which were not quite distinct between the farm types. Lack 
of significant differences between regions and farm types may also be due to 
limited statistical power of the current study. The data from Chapters 2 and 3 
could be used to inform sample size calculations for future studies.  
 
Findings in Chapter 3 show potential implications of using different 
thresholds and how that could change the trajectory of interpretation of 
resistance or prevalence as whole. Most studies presented in Chapter 1 reported 
on prevalence of resistant bacteria without defining the type of thresholds which 
were used in interpretation of resistance. In Chapter 3, it was revealed that 
there is a possibility that the prevalence of resistance could be misinterpreted 
(i.e. elevated or underestimated) when ECOFFS or clinical breakpoints are 
applied as opposed to bespoke thresholds generated from specific datasets. 
When distributions of poultry derived E. coli isolates from the present study 
were aligned with EUCAST reference distributions, a move towards lower zone 
sizes was seen for poultry isolates rather than EUCAST reference isolates. This 
suggested that a proportion of isolates from the wild-type normal distribution 
could easily be misclassified as resistant based on EUCAST distributions. This is 
an important issue because there was quite significant difference in AMR 
prevalence as indicated by EUCAST ECOFFS compared to COWT values calculated 
from poultry data. In the EUCAST data, a significant portion of the data 
originated from SENTRY, a human centred dataset which has almost no 
representation of data from Africa. Thus, the EUCAST data may not reflect the 
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WT distribution for human or poultry E. coli isolates obtained from Africa and 
AMR prevalence in Tanzania may be overestimated if EUCAST thresholds are 
used. Likewise, the MYSTIC (Meropenem Yearly Susceptibility Test Information 
Collection) dataset combines data from medical centres and is also human 
focused and biased towards high income countries, resulting in potential 
misinterpretation of AMR data from LMICs. Clinical breakpoints are set for 
human therapeutic purposes, yet we have numerous studies that utilise the same 
breakpoints to interpret animal data. Despite similarities in prevalence based on 
clinical breakpoints and COWT in the current study, this progressively 
demonstrates that there is a general lack of understanding of origin, purpose and 
interpretation of these thresholds. Likewise, it demonstrates that none of these 
reference thresholds can be utilised as universal benchmarks in interpretation of 
resistance for animal and human studies across the world. Moreover, it raises 
concerns particularly in low income countries, where extremely stringent 
financial priorities have to be set based on research outputs yet potential 
misinterpretation of prevalence of resistance could occur. Going forward, 
critical investigation should be conducted on the current thresholds, in addition, 
to incorporation of data from low resource countries while generating these 
thresholds. When generating such data, stringent quality control of media and 
procedures, e.g. as described in Chapter 3 should be implemented to avoid some 
of the difficulties that were encountered in the current study, particularly in 
Chapter 2, and to ensure that differences in AMR prevalence are only due to 
differences in interpretation or true differences in prevalence, and not to 
differences in methodology.  
 
4.2 Conclusion and Outlook 
From Chapter 1, it is clear that AMR is of global concern and that animal 
agriculture may contribute to the problem. In Tanzania, the poultry sector could 
be a major contributor because of its rapid growth, which is linked to 
urbanisation and increasing consumer wealth in urban areas and drives 
intensification of poultry production. In Chapter 2, prevalence of AMR across 
four scales of intensification was explored for coliform organisms using the 
breakpoint plate method. Prevalence of AMR against a commonly used 
compound such as tetracycline was high and prevalence of AMR against 
compounds that should not be used in poultry production, such as cephalosporins 
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and imipenem was low but there was no obvious difference between production 
systems. In Chapter 3, using standard antimicrobial susceptibility tests of 
individual confirmed E. coli isolates, the difference in prevalence of AMR to 
different compounds was confirmed. Actual prevalence estimates were highly 
dependent on interpretation criteria. For future studies of the AMR problem in 
poultry in Tanzania, a larger sample size may be needed together with 
consideration of additional socio-economic and environmental drivers of AMR, as 
mentioned in Chapter 4. In addition, scientists and policy makers may need to be 
educated about the different methods for interpretation of results from AST, 
and their impact on reported AMR prevalence estimates. AMR is recognised as a 
One Health problem, and the fact that resistance occurs in poultry even though 
some antimicrobials are not used in poultry indicates that transfer between 
humans and animals is likely to occur, possibly via shared water sources or 
environments. Due to the human, animal and environment dimension of AMR, it 
is important to use a One Health approach when addressing the problem. This 
includes preserving the effectiveness of the existing antimicrobials by 
eliminating their inappropriate use and limiting the spread of infection in 
humans and animals. Additionally, standardised methods are required in 
screening human and animal isolates, however, it is important to recognise as 
this effort is being made that there is not one approach for everything.  
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